Olfactory ensheathing cells	1
collateral	37
the injured adult rat	68
spinal cord M.I. Chuah , * D. Choi-Lundberg , S. Weston , A.J. Vincent , R.S. Chung , J.C. Vickers , and A.K. West NeuroRepair Group , School of Medicine , University of Tasmania , Hobart , Tasmania 7001 , Australia Received 13 February 2003 ; revised 20 August 2003 ; accepted 16 September 2003 Abstract In recent years , injection of olfactory ensheathing cells -LRB- ECs -RRB- into the spinal cord has been used as an experimental strategy to promote regeneration of injured axons	90
spinal cord M.I. Chuah , * D. Choi-Lundberg , S. Weston , A.J. Vincent , R.S. Chung , J.C. Vickers , and A.K. West NeuroRepair Group , School of Medicine , University of Tasmania , Hobart , Tasmania 7001 , Australia Received 13 February 2003	90
spinal cord	90
M.I. Chuah , * D. Choi-Lundberg , S. Weston , A.J. Vincent , R.S. Chung , J.C. Vickers , and A.K. West NeuroRepair Group , School of Medicine , University of Tasmania , Hobart , Tasmania 7001 , Australia	102
M.I. Chuah , * D. Choi-Lundberg , S. Weston , A.J. Vincent , R.S. Chung , J.C. Vickers , and A.K. West NeuroRepair Group , School	102
D. Choi-Lundberg , S. Weston , A.J. Vincent , R.S. Chung , J.C. Vickers , and A.K. West	115
D. Choi-Lundberg	115
S. Weston	133
A.J. Vincent	144
R.S. Chung	158
J.C. Vickers	170
A.K. West	188
NeuroRepair Group	198
Medicine , University of Tasmania , Hobart , Tasmania 7001 , Australia	227
Medicine , University	227
Tasmania , Hobart , Tasmania 7001 , Australia	251
Tasmania , Hobart , Tasmania 7001	251
Australia	284
13	303
February 2003	306
20	329
August 2003	332
16 September 2003 Abstract In recent years , injection of olfactory ensheathing cells -LRB- ECs -RRB- into the spinal cord has been used as an experimental strategy	354
16 September 2003 Abstract	354
recent years	386
injection of olfactory ensheathing cells -LRB- ECs -RRB- into the spinal cord	400
injection	400
olfactory ensheathing cells -LRB- ECs -RRB- into the spinal cord	413
olfactory ensheathing cells -LRB- ECs -RRB-	413
olfactory ensheathing cells	413
ECs	442
the spinal cord	452
an experimental strategy	485
regeneration of injured axons	521
regeneration	521
injured axons	537
this study	555
we	567
the effects of transplanting encapsulated ECs with those injected directly into the spinal cord	584
the effects	584
ECs	626
those injected directly into the spinal cord	635
those	635
the spinal cord	664
The dorsal columns of adult rats	681
The dorsal columns	681
adult rats	703
T8 -- 9 and rats in experimental groups received either EC-filled porous polymer capsules or culture medium -LRB- CM -RRB- - filled capsules with ECs injected at the injury site	726
T8 -- 9 and rats in experimental groups received either EC-filled porous polymer capsules or culture medium -LRB- CM -RRB- -	726
T8	726
9 and rats in experimental groups	729
9	729
rats in experimental groups	735
rats	735
experimental groups	743
either EC-filled porous polymer capsules or culture medium -LRB- CM -RRB-	772
either EC-filled porous polymer capsules or culture medium	772
EC-filled porous polymer capsules	779
culture medium	816
CM	832
capsules	843
ECs injected at the injury site	857
ECs	857
the injury site	873
Control rats	890
three groups : -LRB- 1 -RRB- uninjured , -LRB- 2 -RRB- lesion with transplantation of CM-filled capsules and -LRB- 3 -RRB- lesion with transplantation of CM-filled capsules and injections of CM	911
three groups	911
-LRB- 1 -RRB- uninjured , -LRB- 2 -RRB- lesion with transplantation of CM-filled capsules and -LRB- 3 -RRB- lesion with transplantation of CM-filled capsules and injections of CM	925
uninjured	929
, -LRB- 2 -RRB- lesion with transplantation of CM-filled capsules and -LRB- 3 -RRB- lesion with transplantation	938
, -LRB- 2 -RRB- lesion with transplantation of CM-filled capsules	938
-LRB- 2 -RRB- lesion with transplantation	940
-LRB- 2 -RRB- lesion with	940
lesion	944
CM-filled	975
-LRB- 3 -RRB- lesion with transplantation	998
lesion	1002
transplantation	1014
CM-filled capsules and injections	1033
CM	1070
Three weeks	1074
injury	1092
Fluororuby	1100
the hindlimb motor and somatosensory cortex	1129
corticospinal neurons	1182
Observations	1205
there	1233
a few regenerating fibres , up to 10 , in the EC-treated groups	1244
a few regenerating fibres , up to 10 ,	1244
a few regenerating fibres	1244
10	1277
the EC-treated groups	1284
rats that received encapsulated ECs	1310
rats	1310
ECs	1342
regenerating fibres	1347
close association	1383
the capsule	1406
Rats that received EC injections demonstrated a significant increase in the number of collateral branches from the intact ventral corticospinal tract -LRB- vCST -RRB- compared with the corresponding control , CM-injected group -LRB- P = 0.003 -RRB- , while a trend for increased collateral branches was observed in rats that received encapsulated ECs -LRB- P = 0.07 -RRB- .	1419
Rats that received EC injections demonstrated a significant increase in the number of collateral branches from the intact ventral corticospinal tract -LRB- vCST -RRB- compared with the corresponding control , CM-injected group -LRB- P = 0.003 -RRB- , while a trend for increased collateral branches was observed in rats that received	1419
Rats	1419
EC injections	1438
a significant increase	1465
the number of collateral branches	1491
the number	1491
collateral branches	1505
the intact ventral corticospinal tract -LRB- vCST -RRB-	1530
the intact ventral corticospinal tract	1530
vCST	1570
the corresponding control , CM-injected group -LRB- P = 0.003 -RRB-	1590
the corresponding control	1590
CM-injected group -LRB- P = 0.003 -RRB-	1617
CM-injected group	1617
P	1637
0.003	1641
a trend for increased collateral branches	1655
a trend	1655
increased collateral branches	1667
rats that received	1713
rats	1713
ECs -LRB- P = 0.07 -RRB-	1745
ECs	1745
P	1751
0.07	1755
Introduction Traumatic injury to the spinal cord	1763
Introduction Traumatic injury	1763
the spinal cord	1796
a series of cellular reactions that often result in wide ranging functional deficits -LRB- e.g. , reviews by Fawcett and Asher , 1999 ; Schwab and Bartholdi , 1996 -RRB-	1821
a series	1821
cellular reactions	1833
functional deficits -LRB- e.g. , reviews by Fawcett and Asher , 1999 ; Schwab and Bartholdi , 1996 -RRB-	1886
functional deficits	1886
e.g. , reviews by Fawcett and Asher , 1999 ; Schwab and Bartholdi , 1996	1907
e.g. , reviews by Fawcett and Asher	1907
e.g.	1907
reviews by Fawcett and Asher	1913
reviews	1913
Fawcett and Asher	1924
1999 ; Schwab	1943
1999	1943
Schwab	1949
Bartholdi , 1996	1960
Bartholdi	1960
1996	1971
the first few days of injury	1985
the first few days	1985
injury	2007
there	2015
massive neuronal and glial cell death -LRB- Emery et al. , 1998 -RRB-	2024
massive neuronal and glial cell death	2024
Emery	2063
et al. , 1998	2069
et al.	2069
1998	2077
Axons distal to the injury site	2084
Axons	2084
the injury site	2100
reactive astrocytes	2133
scar tissue , which inhibits subsequent axonal regrowth by a combination of mechanical and trophic mechanisms -LRB- Lindsay , 1986 -RRB-	2168
scar tissue	2168
subsequent axonal regrowth	2196
a combination of mechanical and trophic mechanisms -LRB- Lindsay , 1986 -RRB-	2226
a combination	2226
mechanical and trophic mechanisms -LRB- Lindsay , 1986 -RRB-	2243
mechanical and trophic mechanisms	2243
Lindsay	2278
1986	2287
The injury site	2294
a complex environment containing reactive astrocytes , fibroblasts , immune cells and a mix of growth factors , inhibitory factors , cytokines and other agents	2313
a complex environment	2313
reactive astrocytes , fibroblasts , immune cells and a mix of growth factors , inhibitory factors , cytokines and other agents	2346
reactive astrocytes	2346
fibroblasts	2367
immune cells	2380
a mix of growth factors , inhibitory factors , cytokines and other agents	2397
a mix	2397
growth factors , inhibitory factors , cytokines and other agents	2406
growth factors	2406
inhibitory factors	2422
cytokines	2442
other agents	2456
some	2470
some	2487
the surface of specific cells -LRB- Schwab and Bartholdi , 1996 -RRB-	2508
the surface	2508
specific cells -LRB- Schwab and Bartholdi , 1996 -RRB-	2523
specific cells	2523
Schwab and Bartholdi	2539
1996	2561
light of the restrictive nature of the injured central nervous system	2571
light	2571
the restrictive nature of the injured central nervous system	2580
the restrictive nature	2580
the injured central nervous system	2606
various experimental strategies	2642
this environment	2703
axonal repair	2728
place	2751
One of these	2758
One	2758
these	2765
the use of olfactory ensheathing cells -LRB- ECs -RRB-	2774
the use	2774
olfactory ensheathing cells -LRB- ECs -RRB-	2785
olfactory ensheathing cells	2785
ECs	2814
ECs	2828
the injured spinal cord have resulted in a remarkable degree of axonal regeneration and functional recovery -LRB- e.g. , Imaizumi et al. , 1998 ; Nash et al. , 2002 ; Ramon-Cueto et al. , 1998 -RRB-	2846
the injured spinal cord	2846
a remarkable degree of axonal regeneration and functional recovery -LRB- e.g. , Imaizumi et al. , 1998 ; Nash et al. , 2002 ; Ramon-Cueto et al. , 1998 -RRB-	2887
a remarkable degree	2887
axonal regeneration and functional recovery -LRB- e.g. , Imaizumi et al. , 1998 ; Nash et al. , 2002 ; Ramon-Cueto et al. , 1998 -RRB-	2910
axonal regeneration and functional recovery	2910
regeneration	2917
e.g. , Imaizumi et al. , 1998 ; Nash et al. , 2002 ; Ramon-Cueto et al. , 1998	2955
e.g.	2955
Imaizumi et al. , 1998 ; Nash et al. , 2002 ; Ramon-Cueto et al.	2961
Imaizumi	2961
et al. , 1998 ; Nash et al. , 2002 ; Ramon-Cueto et al.	2970
et al. , 1998	2970
et al.	2970
1998	2978
Nash et al. , 2002	2984
Nash	2984
et al. , 2002	2989
et al.	2989
2002	2997
Ramon-Cueto et al.	3003
Ramon-Cueto	3003
et al.	3015
1998	3023
remyelination of demyelinated axons -LRB- Li et al. , 1997 ; Imaizumi et al. , 1998 -RRB-	3040
remyelination	3040
axons -LRB- Li et al. , 1997 ; Imaizumi et al. , 1998 -RRB-	3070
axons	3070
Li	3077
et al. , 1997 ; Imaizumi et al. , 1998	3080
et al.	3080
1997 ; Imaizumi et al.	3088
1997	3088
Imaizumi et al.	3094
Imaizumi	3094
et al.	3103
1998	3111
the restoration of climbing ability of rats whose spinal cords have undergone complete transection -LRB- Ramon-Cueto et al. , 2000 -RRB-	3145
the restoration	3145
ability of rats whose spinal cords have undergone complete transection -LRB- Ramon-Cueto et al. , 2000 -RRB-	3173
ability	3173
rats whose spinal cords have undergone complete transection -LRB- Ramon-Cueto et al. , 2000 -RRB-	3184
rats	3184
spinal cords	3195
complete transection	3223
Ramon-Cueto	3245
et al. , 2000	3257
et al.	3257
2000	3265
studies	3281
the mechanisms through which ECs operate in the novel environment of the injured spinal cord	3313
the mechanisms	3313
ECs	3342
the novel environment of the injured spinal cord	3357
the novel environment	3357
the injured spinal cord	3382
Results of in vitro studies	3407
Results	3407
studies	3427
ECs	3458
cell surface molecules such as N-CAM , N-cadherin and laminin -LRB- Chuah and Au , 1994 ; Chuah et al. , 1991 ; Treloar et al. , 1996 -RRB-	3470
cell surface molecules	3470
N-CAM , N-cadherin and laminin -LRB- Chuah and Au , 1994 ; Chuah et al. , 1991 ; Treloar et al. , 1996 -RRB-	3501
N-CAM , N-cadherin and laminin	3501
Chuah and Au , 1994 ; Chuah et al. , 1991 ; Treloar et al. , 1996	3532
Chuah and Au	3532
1994 ; Chuah et al. , 1991 ; Treloar et al.	3546
1994	3546
Chuah et al. , 1991 ; Treloar et al.	3552
Chuah	3552
et al. , 1991 ; Treloar et al.	3558
et al. , 1991	3558
et al.	3558
1991	3566
Treloar et al.	3572
Treloar	3572
et al.	3580
1996	3588
They	3595
many growth factors including several forms of neuregulins and some neurotrophins -LRB- Chuah and West , 2002 ; Chuah et al. , 2000 ; Woodhall et al. , 2001 -RRB-	3613
many growth factors	3613
several forms of neuregulins and some neurotrophins -LRB- Chuah and West , 2002 ; Chuah et al. , 2000 ; Woodhall et al. , 2001 -RRB-	3643
several forms	3643
neuregulins and some neurotrophins -LRB- Chuah and West , 2002 ; Chuah et al. , 2000 ; Woodhall et al. , 2001 -RRB-	3660
neuregulins	3660
some neurotrophins -LRB- Chuah and West , 2002 ; Chuah et al. , 2000 ; Woodhall et al. , 2001 -RRB-	3676
some neurotrophins	3676
Chuah and West , 2002 ; Chuah et al. , 2000 ; Woodhall et al. , 2001	3696
Chuah and West	3696
2002 ; Chuah et al. , 2000 ; Woodhall et al.	3712
2002	3712
Chuah et al. , 2000 ; Woodhall et al.	3718
Chuah	3718
et al. , 2000 ; Woodhall et al.	3724
et al. , 2000	3724
et al.	3724
2000	3732
Woodhall et al.	3738
Woodhall	3738
et al.	3747
2001	3755
It	3762
the reparative properties of ECs in the spinal cord	3786
the reparative properties	3786
ECs in the spinal cord	3815
ECs	3815
the spinal cord	3822
these soluble growth factors	3859
direct contact between ECs and host tissue	3899
direct contact	3899
ECs and host tissue	3922
spinal cord repair	3957
the present study	3980
we	3999
the effect of encapsulated ECs with that of ECs injected directly into the injured spinal cord	4016
the effect	4016
ECs	4043
that of ECs injected directly into the injured spinal cord	4052
that	4052
ECs injected directly into the injured spinal cord	4060
ECs	4060
the injured spinal cord	4087
The dorsal corticospinal tract -LRB- dCST -RRB-	4112
The dorsal corticospinal tract	4112
dCST	4144
T8	4161
9 and the extent of repair	4164
9	4164
the extent of repair	4170
the extent	4170
repair	4184
segments of the spinal cord rostral and caudal	4250
segments	4250
the spinal cord rostral and caudal	4262
the spinal cord rostral	4262
caudal	4290
the lesion	4300
We	4312
the response of the uninjured ventral corticospinal tract -LRB- vCST -RRB-	4338
the response	4338
the uninjured ventral corticospinal tract -LRB- vCST -RRB-	4354
the uninjured ventral corticospinal tract	4354
vCST	4397
ECs that are encapsulated or implanted directly into the spinal cord	4406
ECs	4406
the spinal cord	4459
our knowledge	4479
this	4494
the first study to examine the influence of ECs on collateral sprouting in the spinal cord	4502
the influence of ECs	4529
the influence	4529
ECs	4546
collateral sprouting in the spinal cord	4553
collateral	4553
the spinal cord	4577
Materials and methods All procedures involving animals	4595
Materials and methods All procedures	4595
Materials	4595
methods All procedures	4609
methods	4609
All procedures	4617
animals	4642
the Animal Experimentation Ethics Committee of the University of Tasmania	4667
the Animal Experimentation Ethics Committee	4667
the University of Tasmania	4714
the University	4714
Tasmania	4732
the Australian Code of Practice for the Care and Use of Animals	4765
the Australian Code	4765
Practice for the Care and Use of Animals	4788
Practice	4788
the Care and Use	4801
Animals	4821
Scientific Purposes	4833
Ensheathing cell purification and encapsulation Ensheathing cells	4854
Ensheathing cell purification	4854
encapsulation Ensheathing cells	4888
the basis of the method of Chuah and Teague -LRB- 1999 -RRB-	4950
the basis	4950
the method of Chuah and Teague -LRB- 1999 -RRB-	4963
the method	4963
Chuah and Teague	4977
1999	4995
modifications -LRB- Vincent et al. , 2003 -RRB-	5006
modifications	5006
Vincent	5021
et al. , 2003	5029
et al.	5029
2003	5037
the yield of ECs	5055
the yield	5055
ECs	5068
a high level of purity	5090
a high level	5090
purity	5106
The olfactory nerve layer -LRB- ONL -RRB- and mucosa -LRB- OM -RRB-	5114
The olfactory nerve layer -LRB- ONL -RRB-	5114
The olfactory nerve layer	5114
ONL	5141
mucosa -LRB- OM -RRB-	5150
mucosa	5150
OM	5158
3-day-old hooded Wistar rats euthanised in ice	5181
3-day-old hooded Wistar rats	5181
ice	5224
The ONL	5229
the glomerular and deeper layers of the olfactory bulb	5258
the glomerular and deeper layers	5258
the olfactory bulb	5294
the OM	5317
both sides of the nasal septum	5341
both sides	5341
the nasal septum	5355
the surrounding respiratory tissue	5391
The pooled tissues	5427
MEM HEPES modification -LRB- MEMH ; Sigma , NSW , Australia -RRB-	5463
MEM HEPES modification	5463
MEMH ; Sigma , NSW , Australia	5487
MEMH	5487
Sigma , NSW , Australia	5493
0.25 % trypsin -LRB- Gibco , NY -RRB- and 0.03 % collagenase -LRB- Sigma -RRB-	5527
0.25 % trypsin -LRB- Gibco , NY -RRB-	5527
0.25 % trypsin	5527
Gibco	5542
NY	5549
0.03 % collagenase -LRB- Sigma -RRB-	5557
0.03 % collagenase	5557
Sigma	5576
15 min at 37jC	5587
15 min	5587
37jC	5597
This incubation	5603
fresh solution , then replaced with culture medium -LRB- CM -RRB- composed of MEM D-valine modification -LRB- Sigma -RRB- supplemented with 10 % dialysed fetal calf serum -LRB- 10000 MW cut-off ; Sigma -RRB- and penicillin -- streptomycin	5643
fresh solution	5643
culture medium -LRB- CM -RRB- composed of MEM D-valine modification -LRB- Sigma -RRB- supplemented with 10 % dialysed fetal calf serum -LRB- 10000 MW cut-off ; Sigma -RRB- and penicillin -- streptomycin	5678
culture medium	5678
CM	5694
MEM D-valine modification -LRB- Sigma -RRB- supplemented with 10 % dialysed fetal calf serum -LRB- 10000 MW cut-off ; Sigma -RRB- and penicillin -- streptomycin	5710
MEM D-valine modification	5710
Sigma	5737
10 % dialysed fetal calf serum -LRB- 10000 MW cut-off ; Sigma -RRB- and penicillin -- streptomycin	5762
10 % dialysed fetal calf serum -LRB- 10000 MW cut-off ; Sigma -RRB-	5762
10 %	5762
dialysed fetal calf serum -LRB- 10000 MW cut-off ; Sigma -RRB-	5766
dialysed fetal calf serum	5766
10000 MW	5793
cut-off ; Sigma	5802
cut-off	5802
Sigma	5811
penicillin -- streptomycin	5822
penicillin	5822
streptomycin	5833
amphotericin B -LRB- Gibco -RRB- -LRB- Tisay and Key , 1999 -RRB-	5846
amphotericin B -LRB- Gibco -RRB-	5846
amphotericin B	5846
Gibco	5862
Tisay and Key	5870
1999	5885
The digested tissue	5892
a sterile nylon gauze -LRB- 80 Am pore size -RRB-	5945
a sterile nylon gauze	5945
80	5968
pore size	5974
10 min at 500 x g. Resuspended cells were plated in CM	6005
10 min at 500	6005
10 min	6005
500	6015
g. Resuspended cells were plated in CM	6021
g.	6021
Resuspended cells	6024
CM	6057
24 h	6067
the culture	6073
10-4 M cytosine-β-D-arabinofuranoside -LRB- AraC ; Sigma -RRB- for 48 h	6102
10-4 M cytosine-β-D-arabinofuranoside -LRB- AraC ; Sigma -RRB-	6102
10-4 M cytosine-β-D-arabinofuranoside	6102
AraC ; Sigma	6141
AraC	6141
Sigma	6147
48 h	6158
the population of fibroblasts	6175
the population	6175
fibroblasts	6193
ECs	6215
125 µg/ml bovine pituitary extract -LRB- Sigma -RRB-	6236
125 µg/ml bovine pituitary extract	6236
Sigma	6272
2 days	6283
passage	6297
encapsulation	6310
ECs	6325
25-cm2 flasks -LRB- Sarstedt , NC -RRB-	6347
25-cm2 flasks	6347
Sarstedt	6362
NC	6372
500 x g	6392
500	6392
g	6398
CM	6419
means of a Hamilton syringe	6426
means	6426
a Hamilton syringe	6435
they	6455
a polyvinylidene fluoride -LRB- PVDF -RRB- hollow fibre of 1.0 - mm diameter with a MW cut-off of 300 000 Da -LRB- Spectrum , CA -RRB-	6481
a polyvinylidene fluoride -LRB- PVDF -RRB- hollow fibre of 1.0	6481
a polyvinylidene fluoride -LRB- PVDF -RRB- hollow fibre	6481
1.0	6530
mm diameter with a MW cut-off of 300 000 Da -LRB- Spectrum , CA -RRB-	6535
mm diameter	6535
a MW cut-off of 300 000 Da -LRB- Spectrum , CA -RRB-	6552
a MW cut-off of 300 000 Da	6552
300 000	6568
Spectrum	6580
CA	6590
each end of the fibre	6610
each end	6610
the fibre	6622
heat sealed to form a capsule measuring 6 -- 8 mm long and containing about 105 ECs	6636
heat	6636
a capsule	6656
6 -- 8 mm long	6676
6	6676
8 mm	6678
105 ECs	6709
Control capsules	6718
CM	6745
no ECs	6759
All capsules	6767
CM overnight at 37 °C in 5 % carbon dioxide	6795
CM overnight	6795
37 °C in 5 % carbon dioxide	6811
37 °C	6811
5 % carbon dioxide	6819
the spinal cord	6861
the following day	6877
Hoechst blue-labeling of ensheathing cells	6896
Hoechst blue-labeling	6896
ensheathing cells	6921
Ensheathing cells that were used for direct injections into the spinal cord were prelabeled with Hoechst 33342	6939
Ensheathing cells	6939
direct injections	6976
the spinal cord were prelabeled with Hoechst 33342	6999
the spinal cord	6999
Hoechst 33342	7036
Sigma	7051
One day	7059
injection	7074
ECs that were growing in a 25-cm2 flask	7085
ECs	7085
a 25-cm2 flask	7110
10 ng/ml	7143
Hoechst 33342	7152
CM	7169
a stock of 10 mg/ml in dimethyl sulfoxide	7189
a stock	7189
10 mg/ml in dimethyl sulfoxide	7200
10 mg/ml	7200
dimethyl sulfoxide	7212
The cells	7232
40 min at 37 °C	7261
40 min	7261
37 °C	7271
four times	7284
MEMH	7298
fresh CM	7319
A small sample of cells	7329
A small sample	7329
cells	7347
the flask	7369
ultraviolet filter	7396
the staining	7429
implantation	7470
the CM	7484
any unincorporated Hoechst	7521
the solution	7568
A fresh flask of unlabeled cells	7582
A fresh flask	7582
unlabeled cells	7599
overnight with this medium	7629
overnight	7629
this medium	7644
ultraviolet filter	7674
Only labeling of a barely detectable level	7694
Only labeling	7694
a barely detectable level	7711
This procedure	7751
a precautionary measure	7778
that host tissues	7815
excess	7853
solution	7867
the process of injecting ECs into the spinal cord	7883
the process	7883
ECs	7908
the spinal cord	7917
Thirty minutes	7934
injection	7956
ECs	7967
half the flask	7989
500 x g	8020
500	8020
g	8026
a concentration of about 104 cells/µl CM	8047
a concentration	8047
104 cells/µl CM	8072
Spinal lesion surgeries Adult rats	8089
Spinal lesion surgeries	8089
Adult rats	8113
270	8133
380 g	8137
3 % isoflurane with oxygen	8167
3 % isoflurane	8167
oxygen	8186
2 -- 2.5 % isoflurane with oxygen	8212
2	8212
2.5 % isoflurane with oxygen	8214
2.5 % isoflurane	8214
oxygen	8235
0.5 l/min	8245
the surgery	8266
Rats	8279
0.1 ml/kg Rimadyl -LRB- carprofen 50 mg/ml , a nonsteroidal anti-inflammatory and analgesic ; Pfizer Animal Health , UK -RRB-	8318
0.1 ml/kg Rimadyl	8318
carprofen 50 mg/ml , a nonsteroidal anti-inflammatory and analgesic ; Pfizer Animal Health , UK	8337
carprofen 50 mg/ml	8337
a nonsteroidal anti-inflammatory	8357
analgesic ; Pfizer Animal Health , UK	8394
analgesic	8394
Pfizer Animal Health , UK	8405
Pfizer Animal Health	8405
UK	8427
0.1 ml/kg Norocillin L.A. -LRB- procaine penicillin G 150 mg/ml and benzathine penicillin G 112.5 mg/ml ; Norbrook Laboratories , UK -RRB-	8453
0.1 ml/kg Norocillin L.A.	8453
0.1 ml/kg	8453
Norocillin L.A.	8463
procaine penicillin G 150 mg/ml and benzathine penicillin G 112.5 mg/ml ; Norbrook Laboratories , UK	8480
procaine penicillin G 150 mg/ml	8480
procaine penicillin G	8480
150 mg/ml	8502
benzathine penicillin G 112.5 mg/ml ; Norbrook Laboratories , UK	8516
benzathine penicillin G 112.5 mg/ml	8516
benzathine penicillin G	8516
112.5 mg/ml	8540
Norbrook Laboratories , UK	8553
Norbrook Laboratories	8553
UK	8576
40 ml/kg	8607
Hartmann 's saline or 0.9 % saline -LRB- Baxter Healthcare , NSW , Australia -RRB-	8616
Hartmann 's saline	8616
Hartmann 's	8616
0.9 % saline -LRB- Baxter Healthcare , NSW , Australia -RRB-	8637
0.9 % saline	8637
Baxter Healthcare	8650
NSW	8669
Australia	8674
Hair from the back	8686
Hair	8686
the back	8696
clippers	8722
skin	8735
70 % ethanol and povidone-iodine	8753
A sterile surgical drape	8786
the rat and the skin	8827
the rat	8827
the skin	8839
spinous processes of thoracic vertebrae 6 -- 11 -LRB- T6 -- T11 -RRB- was incised and retracted	8853
spinous processes	8853
thoracic vertebrae 6 -- 11 -LRB- T6 -- T11 -RRB- was incised and retracted	8874
thoracic vertebrae	8874
6 -- 11 -LRB- T6 -- T11 -RRB-	8893
6 -- 11	8893
T6 -- T11	8899
T6	8899
T11	8903
Attachments of muscles to T7 -- T10 spinous processes were cut and the muscles retracted .	8935
Attachments of muscles to T7	8935
Attachments	8935
muscles to T7	8950
muscles	8950
T7	8961
T10 spinous processes were cut and the muscles retracted	8964
T10	8964
spinous processes	8968
the muscles	8999
The spinous processes of T8 and T9	9022
The spinous processes	9022
T8 and T9	9047
rongeurs and a laminectomy performed using a dental drill and rongeurs to expose the dorsal spinal cord	9075
rongeurs	9075
a laminectomy performed using a dental drill and rongeurs to expose the dorsal spinal cord	9088
a laminectomy	9088
a dental drill and rongeurs	9118
the dorsal spinal cord	9156
The dura	9180
microscissors	9206
The dorsal columns , which include the dCST ,	9221
The dorsal columns	9221
the dCST	9255
microscissors attached to a stereotaxic arm to a depth of 1.5 mm below the dorsal surface of the spinal cord	9286
microscissors	9286
a stereotaxic arm	9312
a depth of 1.5 mm	9333
a depth	9333
1.5 mm	9344
the dorsal surface of the spinal cord	9357
the dorsal surface	9357
the spinal cord	9379
The width of the cut	9414
The width	9414
the cut	9427
1.5 -- 2.0 mm , centred on the midline	9439
1.5	9439
2.0 mm , centred on the midline	9443
2.0 mm	9443
the midline	9462
Experimental trials	9475
this surgical procedure	9529
a consistent total transection of the dCST	9562
a consistent total transection	9562
the dCST	9596
both sides	9608
Two groups of rats	9620
Two groups	9620
rats	9634
injections of ECs -LRB- n = 6 -RRB- or CM -LRB- n = 5 -RRB-	9648
injections	9648
ECs -LRB- n = 6 -RRB- or CM -LRB- n = 5 -RRB-	9662
ECs	9662
n	9667
6	9671
CM	9677
n	9681
5	9685
placement of a CM-containing PVDF capsule during the same lesion surgery	9700
placement	9700
a CM-containing PVDF capsule during the same lesion surgery	9713
a CM-containing PVDF capsule	9713
the same lesion surgery	9749
ECs suspended in CM or CM	9774
ECs	9774
CM or CM	9791
a 10-Al syringe with 26-s gauge	9823
a 10-Al syringe	9823
26-s gauge	9844
needle -LRB- Hamilton , Reno , NV -RRB-	9864
needle	9864
Hamilton	9872
Reno	9882
NV	9888
the	9898
function of an sp310i syringe pump -LRB- World Precision Instruments , Victoria , Australia -RRB- mounted on a stereotaxic frame	9914
function	9914
an sp310i syringe pump -LRB- World Precision Instruments , Victoria , Australia -RRB- mounted on a stereotaxic frame	9926
an sp310i syringe pump -LRB- World Precision Instruments , Victoria , Australia -RRB-	9926
an sp310i syringe pump	9926
World Precision Instruments , Victoria , Australia	9950
World Precision Instruments , Victoria	9950
Australia	9989
a stereotaxic frame	10011
One microlitre of ECs or CM	10032
One microlitre	10032
ECs or CM	10050
the pump set at an injection rate of 1 µl/min at each of four sites , 0.3 mm to the right and left of the midline and 2 -- 3 mm anterior and posterior to the injury site	10078
the pump	10078
an injection rate of 1 µl/min	10094
an injection rate	10094
1 µl/min	10115
each of four sites , 0.3 mm to the right and left of the midline and 2 -- 3 mm anterior and posterior	10127
each of four sites	10127
each	10127
four sites	10135
0.3 mm to the right	10147
0.3 mm	10147
the right	10157
left of the midline and 2 -- 3 mm anterior and posterior	10171
left of the midline and 2	10171
left	10171
the midline and 2	10179
the midline	10179
2	10195
3 mm anterior and posterior	10197
3 mm	10197
the injury site	10228
All injections	10245
1.0 mm	10265
the dorsal surface of the spinal cord	10280
the dorsal surface	10280
the spinal cord	10302
These	10319
the injected material	10360
the dCST	10398
4 µl of ECs or CM	10422
4 µl	10422
ECs or CM	10430
1 µl/min at the injury site	10456
1 µl/min	10456
the injury site	10468
the midline	10487
each of the five injections	10506
each	10506
the five injections	10514
the needle	10535
place for 1 min	10558
place	10558
1 min	10568
the injections	10585
a PVDF fibre capsule filled with CM	10601
a PVDF fibre capsule	10601
CM	10634
the dorsal median sulcus of the spinal cord , centred anteroposteriorly on the injury site	10655
the dorsal median sulcus	10655
the spinal cord	10683
the injury site	10729
Two additional groups of rats	10746
Two additional groups	10746
rats	10771
a PVDF fibre capsule loaded with ECs -LRB- n = 5 -RRB- or CM -LRB- n = 6 -RRB- , but no injections of ECs or CM , during the same lesion surgery	10785
a PVDF fibre capsule	10785
ECs -LRB- n = 5 -RRB- or CM -LRB- n = 6 -RRB-	10818
ECs	10818
n	10823
5	10827
CM	10833
n	10837
6	10841
no injections of ECs or CM	10849
no injections	10849
ECs or CM	10866
the same lesion surgery	10884
The capsule	10909
the dorsal median sulcus of the spinal cord , centred anteroposteriorly on the injury site	10939
the dorsal median sulcus	10939
the spinal cord	10967
the injury site	11013
the lesion , injections -LRB- in two groups -RRB- and capsule placement -LRB- in all four groups -RRB-	11040
the lesion	11040
injections -LRB- in two groups -RRB- and capsule placement -LRB- in all four groups -RRB-	11052
injections -LRB- in two groups -RRB-	11052
injections	11052
two groups	11067
capsule placement -LRB- in all four groups -RRB-	11083
capsule placement	11083
all four groups	11105
the retracted muscles	11123
5	11163
0 silk and the skin	11165
0 silk	11165
the skin	11176
Michel wound clips	11197
The skin	11217
povidone-iodine	11243
the rat	11263
its individual home cage	11283
a heat lamp for 1 h. Rats	11314
a heat lamp	11314
1 h. Rats	11330
3 days following surgery subcutaneously with 0.1	11364
3 days	11364
surgery subcutaneously with 0.1	11381
surgery	11381
0.1	11409
ml/kg Rimadyl -LRB- carprofen 50 mg/ml -RRB-	11413
ml/kg Rimadyl	11413
carprofen 50 mg/ml	11428
carprofen	11428
50 mg/ml	11438
Cortical injections of Fluororuby	11449
Cortical injections	11449
Fluororuby	11472
the corticospinal tract	11506
rats	11531
Fluororuby -LRB- Molecular Probes , Eugene , OR -RRB-	11555
Fluororuby	11555
Molecular Probes	11567
Eugene	11585
OR	11593
the hindlimb motor and somatosensory cortex , which contains most corticospinal neurons projecting to the lumbosacral enlargement of the spinal cord -LRB- Li et al. , 1990 -RRB-	11602
the hindlimb motor and somatosensory cortex	11602
most corticospinal neurons projecting to the lumbosacral enlargement of the spinal cord -LRB- Li et al. , 1990 -RRB-	11662
most corticospinal neurons	11662
the lumbosacral enlargement of the spinal cord	11703
the lumbosacral enlargement	11703
the spinal cord	11734
Li	11751
et al. , 1990	11754
et al.	11754
1990	11762
Fluororuby injections	11769
3 weeks	11806
spinal lesion surgeries	11820
a group of uninjured rats	11856
a group	11856
uninjured rats	11867
340 -- 365 g -LRB- n = 4 -RRB-	11891
340	11891
365 g -LRB- n = 4 -RRB-	11895
n	11902
4	11906
Rats	11910
Rimadyl , Norocillin L.A. and saline	11952
Rimadyl	11952
Norocillin L.A.	11961
saline	11981
the spinal surgeries	11995
They	12017
a stereotaxic frame with gas anaesthesia mask -LRB- David Kopf Instruments , Tujunga , CA -RRB-	12037
a stereotaxic frame	12037
gas anaesthesia mask -LRB- David Kopf Instruments , Tujunga , CA -RRB-	12062
gas anaesthesia mask	12062
David Kopf Instruments	12084
Tujunga	12108
CA	12117
Scalp hair	12122
clippers , the scalp swabbed with 70 % ethanol and povidone-iodine ,	12150
clippers	12150
the scalp swabbed with 70 % ethanol and povidone-iodine	12160
the scalp	12160
70 % ethanol and povidone-iodine	12183
Scalp flaps	12229
fascia	12260
the skull with cotton tip applicators	12280
the skull	12280
cotton tip applicators	12295
The bregma and lambda	12319
the horizontal plane	12358
the bite bar	12392
Burr holes	12406
the skull above the injection sites at the following coordinates relative to the bregma : 0.9 mm posterior , 2.0 mm lateral ; 1.9 mm posterior , 2.4 mm lateral ; and 2.9 mm posterior , 2.6 mm lateral , on both the right and left -LRB- coordinates on the basis location of hindlimb somatosensory cortex by Paxinos and Watson , 1986 -RRB-	12433
the skull	12433
the injection sites at the following coordinates relative to the bregma : 0.9 mm posterior , 2.0 mm lateral ; 1.9 mm posterior , 2.4 mm lateral ; and 2.9 mm posterior , 2.6 mm lateral , on both the right and left -LRB- coordinates on the basis location of hindlimb somatosensory cortex by Paxinos and Watson , 1986 -RRB-	12449
the injection sites at the following coordinates relative to the bregma : 0.9 mm posterior , 2.0 mm lateral ; 1.9 mm posterior , 2.4 mm lateral ; and 2.9 mm posterior , 2.6 mm lateral , on both the right and left	12449
the injection sites at the following coordinates relative to the bregma	12449
the injection sites	12449
the following coordinates relative to the bregma	12472
the following	12472
the bregma	12510
0.9 mm posterior , 2.0 mm lateral	12522
0.9 mm posterior	12522
2.0 mm lateral	12540
1.9 mm posterior , 2.4 mm lateral	12556
1.9 mm posterior	12556
2.4 mm lateral	12574
2.9 mm posterior , 2.6 mm lateral , on both the right and left	12594
2.9 mm posterior , 2.6 mm lateral ,	12594
2.9 mm posterior	12594
2.6 mm lateral	12612
both the right and left	12631
the basis location of hindlimb somatosensory cortex	12671
the basis location	12671
hindlimb somatosensory cortex	12693
Paxinos and Watson , 1986	12726
Paxinos and Watson	12726
1986	12746
Half a microlitre of Fluororuby solution -LRB- 10 % rhodamine -- dextran , MW 10 000 in water with 0.5 % Triton X100 -RRB-	12753
Half a microlitre of Fluororuby solution	12753
Half	12753
a microlitre of Fluororuby solution	12758
a microlitre	12758
Fluororuby solution	12774
10 % rhodamine -- dextran , MW 10 000 in water with 0.5 % Triton X100	12795
10 % rhodamine	12795
dextran , MW 10 000 in water with 0.5 % Triton X100	12809
dextran	12809
MW 10 000 in water with 0.5 % Triton X100	12818
water with 0.5 %	12831
water	12831
0.5 %	12842
each of the six sites 1.8 mm below the dura at a rate of 0.5 µl/min using a 10 µl Hamilton syringe with 33 gauge needle controlled by an sp310i syringe pump	12876
each	12876
the six sites	12884
1.8 mm	12898
the dura at a rate of 0.5 µl/min using a 10 µl Hamilton syringe with 33 gauge needle controlled by an sp310i syringe pump	12911
the dura	12911
a rate of 0.5 µl/min using a 10 µl Hamilton syringe with 33 gauge needle controlled by an sp310i syringe pump	12923
a rate	12923
0.5 µl/min using a 10 µl Hamilton syringe with 33 gauge needle controlled by an sp310i syringe pump	12933
0.5 µl/min	12933
a 10 µl Hamilton syringe	12950
33 gauge needle controlled by an sp310i syringe pump	12980
33 gauge needle	12980
an sp310i syringe pump	13010
The needle	13034
place for 1 min	13057
place	13057
1 min	13067
each injection	13079
Burr holes	13095
bone wax	13123
the scalp	13136
suture clips	13158
The skin	13172
povidoneiodine	13198
the rat	13217
its individual home cage	13237
a heat lamp for 30 min	13268
a heat lamp	13268
30 min	13284
Rats	13292
2 days following the surgery subcutaneously with 0.1 ml/kg Rimadyl -LRB- carprofen 50 mg/ml -RRB-	13321
2 days	13321
the surgery subcutaneously with 0.1 ml/kg Rimadyl -LRB- carprofen 50 mg/ml -RRB-	13338
the surgery	13338
0.1 ml/kg Rimadyl -LRB- carprofen 50 mg/ml -RRB-	13370
0.1 ml/kg Rimadyl	13370
carprofen 50 mg/ml	13389
carprofen	13389
50 mg/ml	13399
Histology Rats	13410
0.4 ml Nembutal -LRB- 200 mg / kg ; Boehringer Ingelheim , NSW , Australia -RRB- 2 weeks	13449
0.4 ml Nembutal -LRB- 200 mg / kg ; Boehringer Ingelheim , NSW , Australia -RRB-	13449
0.4 ml Nembutal	13449
200 mg	13466
kg ; Boehringer Ingelheim , NSW , Australia	13474
kg	13474
Boehringer Ingelheim , NSW , Australia	13478
2 weeks	13516
injection of Fluororuby	13530
injection	13530
Fluororuby	13543
They	13555
cold phosphate buffered saline -LRB- PBS -RRB- followed by 4 % paraformaldehyde in 0.1 M phosphate buffer -LRB- pH 7.4 -RRB-	13594
cold phosphate	13594
saline -LRB- PBS -RRB- followed by 4 % paraformaldehyde in 0.1 M phosphate buffer -LRB- pH 7.4 -RRB-	13618
saline	13618
PBS	13626
4 % paraformaldehyde in 0.1 M phosphate buffer -LRB- pH 7.4 -RRB-	13643
4 % paraformaldehyde	13643
0.1 M phosphate buffer -LRB- pH 7.4 -RRB-	13666
0.1 M phosphate buffer	13666
pH 7.4	13690
perfusion	13705
the vertebral column and attached brain	13716
the vertebral column	13716
attached brain	13741
cold 4 % buffered paraformaldehyde overnight	13785
cold	13785
paraformaldehyde overnight	13802
The following day	13830
the spinal cord	13849
bloc	13880
the rest of the vertebral column	13890
the rest	13890
the vertebral column	13902
segments	13936
levels indicated in Fig. 1A	13948
levels	13948
Fig. 1A	13968
The rostral ends of spinal cord segments	13977
The rostral ends	13977
spinal cord segments	13997
a solution of 15 % Alcian Blue in 50 % glycerol	14035
a solution	14035
15 % Alcian Blue in 50 % glycerol	14049
50 %	14068
orientation of specimens on the cryostat -LRB- Jung Frigocut 2800E , Leica -RRB-	14095
orientation	14095
specimens on the cryostat -LRB- Jung Frigocut 2800E , Leica -RRB-	14110
specimens	14110
the cryostat -LRB- Jung Frigocut 2800E , Leica -RRB-	14123
the cryostat	14123
Jung Frigocut 2800E , Leica	14137
Jung Frigocut 2800E	14137
Leica	14158
All segments	14166
4 % paraformaldehyde	14203
4 °C	14226
ready for sectioning , at which time they were embedded in Tissue-TekR O.C.T. compound -LRB- ProSciTech , QLD , Australia -RRB-	14236
ready for sectioning , at which time they were embedded in Tissue-TekR O.C.T. compound	14236
sectioning , at which time they were embedded in Tissue-TekR O.C.T.	14246
sectioning	14246
they	14272
Tissue-TekR O.C.T.	14294
ProSciTech	14323
QLD	14335
Australia	14340
The approximately 2.8-cm length of cord containing the capsule	14352
The approximately 2.8-cm length	14352
cord containing the capsule	14387
cord	14387
the capsule	14403
50	14430
thickness	14436
the sagittal plane	14450
all other sections	14475
the transverse plane	14507
the cervical , upper thoracic and midthoracic level	14531
the cervical	14531
upper thoracic and midthoracic level	14545
Sections	14583
water bath	14608
O.C.T. compound	14629
slides coated with 2 % 3-aminopropyltriethoxysilane in acetone -LRB- Sigma -RRB- -LRB- Henderson , 1989 -RRB-	14665
slides	14665
2 % 3-aminopropyltriethoxysilane in acetone -LRB- Sigma -RRB- -LRB- Henderson , 1989 -RRB-	14684
2 % 3-aminopropyltriethoxysilane	14684
acetone -LRB- Sigma -RRB- -LRB- Henderson , 1989 -RRB-	14719
acetone -LRB- Sigma -RRB-	14719
acetone	14719
Sigma	14728
Henderson	14736
1989	14747
It	14754
the sections	14783
the capsule	14810
the rest of the spinal cord tissue	14850
the rest	14850
the spinal cord tissue	14862
an oval-shaped space	14894
the spinal cord section	14918
Sections	14943
1 h in the dark	14976
1 h	14976
the dark	14983
DAKO	15015
fluorescent mounting medium	15020
evaporation	15060
sections	15086
nail polish	15096
the edges of coverslips	15125
the edges	15125
coverslips	15138
Histological examinations	15150
a fluorescence attachment	15196
an Olympus BX50 microscope and images captured using an Olympus DP50 digital camera with the aid of Viewfinder Lite and Studio Lite	15233
an Olympus BX50 microscope	15233
images captured using an Olympus DP50 digital camera with the aid of Viewfinder Lite and Studio Lite	15264
images	15264
an Olympus DP50 digital camera with the aid of Viewfinder Lite and Studio Lite	15286
an Olympus DP50 digital camera	15286
the aid of Viewfinder Lite and Studio Lite	15322
the aid	15322
Viewfinder Lite and Studio Lite	15333
Viewfinder Lite	15333
Studio Lite	15353
1.0 software -LRB- Pixera Corporation -RRB-	15365
1.0 software	15365
Pixera Corporation	15379
the number of dCST fibres	15409
the number	15409
dCST fibres	15423
transverse sections	15438
images	15459
A4 size	15483
A plastic transparency	15504
the fluorescent tract	15543
individual axons	15569
a pen	15607
the counting	15616
Images of vCST at the lower thoracic level	15640
Images	15640
vCST at the lower thoracic level	15650
vCST	15650
the lower thoracic level	15658
a magnification of 450x	15722
a magnification	15722
450x	15741
sagittal sections	15750
an 8-mm length of the spinal cord caudal to the capsule	15769
an 8-mm length	15769
the spinal cord caudal to the capsule	15787
the spinal cord caudal	15787
the capsule	15813
the number of axonal branches	15847
the number	15847
axonal branches	15861
the vCST fibres	15882
All serial sagittal sections of each spinal cord segment	15899
All serial sagittal sections	15899
each spinal cord segment	15931
400 magnification	15973
the number of fibres branching directly from vCST fibres -LRB- as exemplified by branching shown in Fig. 4H -RRB-	15997
the number	15997
fibres branching directly from vCST fibres -LRB- as exemplified by branching shown in Fig. 4H -RRB-	16011
fibres	16011
vCST fibres	16042
Fig. 4H	16092
the number of terminal branches of axons present in the grey matter	16125
the number	16125
terminal branches of axons present in the grey matter	16139
terminal branches	16139
axons present in the grey matter	16160
axons	16160
the grey matter	16177
Terminal branches	16211
an arborisation	16260
a single axon	16291
innervation	16323
the grey matter	16353
the uninjured animals	16373
counts	16396
the corresponding similar level	16421
All counts	16454
a person blinded to the treatment group	16483
a person	16483
the treatment group	16503
Statistical evaluation of counts and comparison among groups	16524
Statistical evaluation	16524
counts and comparison	16550
groups	16578
SigmaStat 2.03 -LRB- Jandel Scientific Software Corporation , San Rafael , CA -RRB- and the results presented in Figs. 6A and B	16605
SigmaStat 2.03 -LRB- Jandel Scientific Software Corporation , San Rafael , CA -RRB-	16605
SigmaStat 2.03	16605
Jandel Scientific Software Corporation	16621
San Rafael	16661
CA	16673
the results presented in Figs. 6A and B	16681
the results	16681
Figs. 6A and B	16706
A one-way ANOVA	16722
differences	16760
groups , followed by multiple pair wise comparison -LRB- Tukey test -RRB-	16778
groups	16778
multiple pair wise comparison -LRB- Tukey test -RRB-	16798
multiple pair wise comparison	16798
Tukey test	16829
A P value of < 0.05	16842
A P value	16842
< 0.05	16855
<	16855
0.05	16857
data	16907
mean F SEM	16930
Results	16943
1	16957
-LRB- A -RRB- Dissected brain and spinal cord of rat .	16960
-LRB- A -RRB-	16960
brain and spinal cord of rat	16974
brain and spinal cord	16974
rat	16999
Arrows	17004
the levels at which the spinal cord is cut into segments	17020
the levels	17020
the spinal cord	17040
segments	17068
Transverse sections -LRB- 50-µm thickness -RRB-	17078
Transverse sections	17078
50-µm thickness	17099
the cervical -LRB- C -RRB- , upper thoracic -LRB- UT -RRB- , mid-thoracic -LRB- MT -RRB- and upper lumbar level	17129
the cervical -LRB- C -RRB-	17129
the cervical	17129
C	17143
upper thoracic -LRB- UT -RRB-	17147
upper thoracic	17147
UT	17163
mid-thoracic -LRB- MT -RRB-	17168
mid-thoracic	17168
MT	17182
upper lumbar level	17190
the bracketed segment	17232
the	17232
segment	17246
The bracketed segment	17256
The	17256
segment	17270
the lesion	17287
Scale	17341
1.5 cm	17353
-LRB- B -RRB- Transverse section of the spinal cord at the mid-thoracic level showing the Fluororuby-labeled dorsal corticospinal tract .	17361
-LRB- B -RRB- Transverse section of the spinal cord at the mid-thoracic level	17361
-LRB- B -RRB- Transverse section	17361
B	17362
the spinal cord at the mid-thoracic level	17387
the spinal cord	17387
the mid-thoracic level	17406
the Fluororuby-labeled dorsal	17437
corticospinal tract	17467
Scale	17488
0.8 mm	17500
Inset	17508
a magnified image of the fibres of the vCST	17520
a magnified image	17520
the fibres of the vCST	17541
the fibres	17541
the vCST	17555
Scale	17565
200 µm	17577
Fig. 2 .	17586
Fig.	17586
2	17591
-LRB- A -RRB- Graphical presentation of the number of	17594
-LRB- A -RRB- Graphical presentation	17594
A	17595
the number of	17624
the number	17624
dorsal corticospinal fibres	17646
the cervical , upper and mid-thoracic level	17677
all groups	17723
The rats which received EC or CM injections also	17735
The rats	17735
EC or CM injections	17759
culture medium -LRB- CM -RRB-	17788
culture medium	17788
CM	17804
capsules placed over the lesion	17819
capsules	17819
the lesion	17840
There	17852
no statistically significant difference among the treatment groups	17862
no statistically significant difference	17862
the treatment groups	17908
-LRB- B -RRB- The number of labeled dorsal corticospinal fibres at the upper and mid-thoracic levels	17930
-LRB- B -RRB-	17930
The number	17934
dorsal corticospinal fibres	17956
the upper and mid-thoracic levels	17987
a percentage of fibres	18034
a percentage	18034
fibres	18050
the cervical level within each group	18060
the cervical level	18060
each group	18086
the uninjured group	18109
all treatment groups	18130
a reduction	18158
the number of dorsal corticospinal fibres	18173
the number	18173
dorsal corticospinal fibres	18187
the cervical to the mid-thoracic level	18220
the cervical	18220
the mid-thoracic level	18236
The data	18260
many of the corticospinal neurons	18288
many	18288
the corticospinal neurons	18296
5 weeks	18336
Data	18357
mean ± SEM	18379
Fig. 3 .	18392
Fig.	18392
3	18397
Tracing of a typical sagittal section of the spinal cord showing the cavity which marks the location of the capsule -LRB- * -RRB- and its spatial orientation with the dorsal corticospinal tract -LRB- dCST -RRB- .	18400
Tracing	18400
a typical sagittal section	18411
the spinal cord showing the cavity which marks the location of the capsule -LRB- * -RRB- and its spatial orientation with the dorsal corticospinal tract -LRB- dCST -RRB-	18441
the spinal cord	18441
the cavity which marks the location of the capsule -LRB- * -RRB- and its spatial orientation with the dorsal corticospinal tract -LRB- dCST -RRB-	18465
the cavity	18465
the location of the capsule -LRB- * -RRB- and its spatial orientation with the dorsal corticospinal tract -LRB- dCST -RRB-	18488
the location of the capsule -LRB- * -RRB-	18488
the location	18488
the capsule -LRB- * -RRB-	18504
the capsule	18504
its spatial orientation with the dorsal corticospinal tract -LRB- dCST -RRB-	18524
its spatial orientation	18524
the dorsal corticospinal tract -LRB- dCST -RRB-	18553
the dorsal corticospinal tract	18553
dCST	18585
The grey matter	18592
the middle one-third of the section	18620
the middle one-third	18620
the section	18644
The labeled arrows	18657
the approximate locations	18685
Fig. 4	18722
R = rostral , C = caudal .	18742
R = rostral	18742
C = caudal	18755
Scale	18767
2.5 mm	18779
Fig. 4 .	18788
Fig.	18788
4	18793
Longitudinal sections of spinal cord segment containing lesion and capsule , 2 weeks after injection of Fluororuby .	18796
Longitudinal sections of spinal cord segment	18796
Longitudinal sections	18796
spinal cord segment	18821
lesion and capsule , 2 weeks after injection of Fluororuby	18852
lesion and capsule	18852
2 weeks after injection of Fluororuby	18872
2 weeks	18872
injection of Fluororuby	18886
injection	18886
Fluororuby	18899
`` capsule ''	18911
the cavity which previously housed a capsule containing ECs	18929
the cavity	18929
a capsule	18964
ECs	18985
-LRB- A -RRB- During post-lesion recovery , the capsule has been displaced ventrally in the spinal cord and appears to be in the path of the	18990
-LRB- A -RRB-	18990
post-lesion recovery	19001
the capsule	19023
the spinal cord	19067
the path of the	19104
the path	19104
the	19116
dorsal corticospinal tract	19130
Nerve sprouts projecting from the sides of the tract -LRB- asterisk -RRB-	19158
Nerve sprouts	19158
the sides of the tract -LRB- asterisk -RRB-	19188
the sides	19188
the tract -LRB- asterisk -RRB-	19201
the tract	19201
asterisk	19212
higher magnification	19237
Scale	19259
800 µm	19271
-LRB- B -RRB- Arrow	19279
-LRB- B -RRB-	19279
Arrow	19283
a fibre sprouting from the dorsal corticospinal tract -LRB- dCST -RRB- in the area marked by asterisk in A	19299
a fibre	19299
the dorsal corticospinal tract -LRB- dCST -RRB-	19322
the dorsal corticospinal tract	19322
dCST	19354
the area marked by asterisk in A	19363
the area	19363
asterisk in A	19382
asterisk	19382
The fibre	19397
an arborisation of fine sprouts	19415
an arborisation	19415
fine sprouts	19434
Scale	19448
300 µm	19460
-LRB- C -RRB- Arrows	19468
two fine nerve fibres	19488
the tissue	19521
the EC-containing capsule	19542
Scale	19569
250 µm	19581
-LRB- D -RRB- Arrows	19589
a nerve fibre running close to the ventral edge of the capsule -LRB- C -RRB- containing ECs	19609
a nerve fibre	19609
close	19631
the ventral edge of the capsule -LRB- C -RRB-	19640
the ventral edge	19640
the capsule -LRB- C -RRB-	19660
the capsule	19660
C	19673
ECs	19687
Scale	19692
700 µm	19704
-LRB- E -RRB- Regenerating nerve fibres -LRB- arrows -RRB- running close to the EC-containing capsule , curving around its caudal edge and sandwiched between the capsule and clusters of brightly fluorescent cells , presumably macrophages .	19712
-LRB- E -RRB-	19712
nerve fibres -LRB- arrows -RRB- running close to the EC-containing capsule , curving around its caudal edge and sandwiched between the capsule and clusters of brightly fluorescent cells , presumably macrophages	19729
nerve fibres -LRB- arrows -RRB- running close to the EC-containing capsule , curving around its caudal edge	19729
nerve fibres -LRB- arrows -RRB-	19729
nerve fibres	19729
arrows	19743
the EC-containing capsule	19768
its caudal edge	19810
sandwiched between the capsule and clusters of brightly fluorescent cells , presumably macrophages	19830
the capsule and clusters of brightly fluorescent cells	19849
the capsule and clusters	19849
brightly fluorescent cells	19877
Scale	19929
180 µm	19941
-LRB- F -RRB- Section from spinal cord bearing lesion	19949
-LRB- F -RRB-	19949
spinal cord bearing lesion	19966
ECs	20007
capsule	20033
the culture medium	20052
A nerve fibre -LRB- arrows -RRB-	20072
A nerve fibre	20072
arrows	20087
the caudal edge of the capsule	20126
the caudal edge	20126
the capsule	20145
Scale	20158
400 µm	20170
-LRB- G -RRB- Arborising fine nerve sprouts -LRB- arrow -RRB-	20178
-LRB- G -RRB-	20178
fine nerve sprouts -LRB- arrow -RRB-	20193
fine nerve sprouts	20193
arrow	20213
aggregates of fluorescent cells , presumably macrophages	20261
aggregates	20261
fluorescent cells , presumably macrophages	20275
fluorescent cells	20275
macrophages	20305
Scale	20318
150 µm	20330
-LRB- H -RRB- Section from a region of spinal cord caudal to the lesion and which received encapsulated ECs .	20338
-LRB- H -RRB- Section from a region of spinal cord caudal to the lesion and which received	20338
Section	20342
a region of spinal cord caudal to the lesion and which received	20355
a region of spinal cord caudal to the lesion	20355
a region	20355
spinal cord caudal to the lesion	20367
spinal cord caudal	20367
the lesion	20389
ECs	20432
A collateral branch -LRB- arrows -RRB- from the ventral corticospinal tract in the ventral funiculus	20437
A collateral branch -LRB- arrows -RRB-	20437
A collateral branch	20437
arrows	20458
the ventral corticospinal tract in the ventral funiculus	20471
the ventral corticospinal tract	20471
the ventral funiculus	20506
across the grey matter and then projects	20536
the grey matter	20543
the region where the original dorsal corticospinal tract was located	20589
the region	20589
the original dorsal corticospinal tract	20606
Scale	20659
600 µm	20671
-LRB- I -RRB- Similar section caudal to the lesion from a different rat which received encapsulated ECs .	20679
-LRB- I -RRB- Similar section	20679
I	20680
caudal to the lesion from a different rat which received encapsulated ECs	20699
caudal	20699
the lesion from a different rat which received encapsulated ECs	20709
the lesion	20709
a different rat which received encapsulated ECs	20725
a different rat	20725
ECs	20769
Fibres of the vCST -LRB- arrowheads -RRB-	20774
Fibres	20774
the vCST -LRB- arrowheads -RRB-	20784
the vCST	20784
arrowheads	20794
the ventral funiculus	20830
A caudally projecting fibre -LRB- arrows -RRB- in the dorsal funiculus	20853
fibre -LRB- arrows -RRB- in the dorsal	20875
fibre -LRB- arrows -RRB-	20875
fibre	20875
arrows	20882
the dorsal	20893
the fibre network present in the grey matter	20930
the fibre network	20930
the grey matter	20959
Scale	20976
800 µm	20988
Fig. 5 .	20997
Fig.	20997
5	21002
-LRB- A -RRB- Olfactory ensheathing cells labeled with Hoescht blue before implantation .	21005
-LRB- A -RRB- Olfactory ensheathing	21005
A	21006
cells labeled with Hoescht blue before implantation	21031
cells	21031
Hoescht blue	21050
implantation	21070
Scale	21084
40 µm	21096
-LRB- B -RRB- Injection site -LRB- asterisk -RRB- in spinal cord	21103
-LRB- B -RRB- Injection site	21103
-LRB- B -RRB-	21103
Injection site	21107
asterisk	21123
spinal cord	21136
aggregates of ECs prelabeled with Hoescht blue	21162
aggregates	21162
ECs prelabeled with Hoescht blue	21176
ECs	21176
Hoescht blue	21196
Ensheathing cells	21210
their blue fluorescence -LRB- arrow , inset -RRB- while the autofluorescence of macrophages -LRB- arrowhead , inset -RRB- is yellowish crystalloid in appearance	21252
their blue fluorescence -LRB- arrow , inset -RRB-	21252
their blue fluorescence	21252
arrow , inset	21277
arrow	21277
the autofluorescence of macrophages -LRB- arrowhead , inset -RRB- is yellowish crystalloid in appearance	21297
the autofluorescence	21297
macrophages -LRB- arrowhead , inset -RRB- is yellowish crystalloid in appearance	21321
macrophages -LRB- arrowhead , inset -RRB-	21321
macrophages	21321
arrowhead , inset	21334
arrowhead	21334
yellowish crystalloid in appearance	21355
yellowish crystalloid	21355
appearance	21380
this specimen	21395
no fibres	21410
the injection site or ECs	21437
the injection site	21437
ECs	21459
Scale bar = 250	21464
Scale bar	21464
250	21476
Scale	21484
inset = 125 µm	21497
inset	21497
125 µm	21505
-LRB- C -RRB- Only a few ECs -LRB- arrow -RRB-	21513
-LRB- C -RRB- Only a few ECs	21513
-LRB- C -RRB-	21513
Only a few ECs	21517
arrow	21533
this injection site -LRB- asterisk -RRB-	21557
this injection site	21557
asterisk	21578
Scale	21589
180 µm	21601
Fig. 6 .	21610
Fig.	21610
6	21615
-LRB- A -RRB- Graphical presentation of the ratio of axonal collateral branches relative to the number of ventral corticospinal fibres .	21618
-LRB- A -RRB- Graphical presentation of the ratio of axonal collateral branches	21618
-LRB- A -RRB- Graphical presentation	21618
A	21619
the ratio of axonal collateral branches	21648
the ratio	21648
axonal collateral branches	21661
the number of ventral corticospinal fibres	21700
the number	21700
ventral corticospinal fibres	21714
The group which received EC injections	21744
The group	21744
EC injections	21769
significantly more collateral branches	21787
the group which received only culture medium -LRB- CM -RRB- injections -LRB- P = 0.003 -RRB-	21831
the group	21831
culture medium -LRB- CM -RRB- injections	21861
CM	21877
P	21894
0.003	21898
these two groups	21909
a capsule containing CM	21927
a capsule	21927
CM	21948
the spinal cord	21972
comparison	21992
the group that received encapsulated ECs	22004
the group	22004
ECs	22041
a similar trend of increased collateral branching although the difference with the corresponding control was not statistically significant -LRB- P = 0.07 -RRB-	22052
a similar trend	22052
increased collateral branching although the difference with the corresponding control was not statistically significant -LRB- P = 0.07 -RRB-	22071
increased collateral	22071
the difference with the corresponding control	22111
the difference	22111
the corresponding control	22131
P = 0.07	22193
P	22193
= 0.07	22195
There	22204
no statistical difference between the group that received EC injections with the one that received encapsulated ECs -LRB- P = 1.00 -RRB-	22214
no statistical difference	22214
the group that received EC injections with the one that received encapsulated ECs -LRB- P = 1.00 -RRB-	22248
the group	22248
EC injections	22272
the one that received encapsulated ECs	22291
the one	22291
ECs	22326
P	22332
1.00	22336
-LRB- B -RRB- Graphical presentation of the ratio of fibre terminations in the grey matter relative to the number of ventral corticospinal fibres .	22343
-LRB- B -RRB- Graphical presentation of the ratio of fibre terminations in the grey matter	22343
-LRB- B -RRB- Graphical presentation	22343
B	22344
the ratio of fibre terminations in the grey matter	22373
the ratio	22373
fibre terminations in the grey matter	22386
fibre terminations	22386
the grey matter	22408
the number of ventral corticospinal fibres	22436
the number	22436
ventral corticospinal fibres	22450
The two groups which received either EC injections or encapsulated ECs	22480
The two groups	22480
EC injections	22517
ECs	22547
a trend of increased ratio of terminating fibres in the grey matter caudal to the lesion	22558
a trend	22558
increased ratio of terminating fibres in the grey matter caudal to the lesion	22569
increased ratio	22569
fibres in the grey matter caudal	22600
fibres	22600
the grey matter caudal	22610
the lesion	22636
Data	22648
mean ± SEM	22670
Histology and axonal labeling Previous studies	22683
Histology	22683
axonal labeling Previous studies	22697
corticospinal neurons	22746
the motor cortex	22792
some other cortical areas including the supplementary motor area , prefrontal cortex and somatosensory cortex -LRB- Li et al. , 1990 ; Miller , 1987 -RRB-	22821
some other cortical areas	22821
the supplementary motor area , prefrontal cortex and somatosensory cortex -LRB- Li et al. , 1990 ; Miller , 1987 -RRB-	22857
the supplementary motor area	22857
prefrontal cortex and somatosensory cortex -LRB- Li et al. , 1990 ; Miller , 1987 -RRB-	22887
prefrontal cortex and somatosensory cortex	22887
Li	22931
et al. , 1990 ; Miller , 1987	22934
et al.	22934
1990 ; Miller	22942
1990	22942
Miller	22948
1987	22956
the basis these findings and several experimental trials	22966
the basis these findings	22966
the basis	22966
these findings	22976
several experimental trials	22995
we	23024
bilateral injection of Fluororuby into the hindlimb motor and somatosensory cortex	23043
bilateral injection	23043
Fluororuby into the hindlimb motor and somatosensory cortex	23066
Fluororuby	23066
the hindlimb motor and somatosensory cortex	23082
intense labeling of the corticospinal tracts -LRB- Fig. 1B -RRB-	23148
intense labeling	23148
the corticospinal tracts -LRB- Fig. 1B -RRB-	23168
the corticospinal tracts	23168
Fig. 1B	23194
the uninjured rat	23207
the number of fibres in the bilateral dCST	23226
the number	23226
fibres in the bilateral dCST	23240
fibres	23240
the bilateral dCST	23250
339 ± 18 , 348 ± 11 and 284 ± 28	23278
339 ± 18	23278
339	23278
18	23284
348 ± 11	23288
348	23288
11	23294
284 ± 28	23301
284	23301
28	23307
the cervical , upper and middle thoracic levels	23313
Fig. 2A	23375
The fibres	23385
compact arrangement	23412
two well-defined tracts	23435
The smaller component of vCST	23460
The smaller component	23460
vCST	23485
55 ± 4 fibres	23499
55	23499
4 fibres	23504
the mid-thoracic level	23528
fibres	23555
a wide area of the ventral funiculus	23594
a wide area	23594
the ventral funiculus	23609
previous studies -LRB- Liang et al. , 1991 ; Weidner et al. , 2001 -RRB-	23647
previous studies	23647
Liang	23665
et al. , 1991 ; Weidner et al. , 2001	23671
et al.	23671
1991 ; Weidner et al.	23679
1991	23679
Weidner et al.	23685
Weidner	23685
et al.	23693
2001	23701
we	23708
a few corticospinal fibres	23735
fewer than six on each side	23781
fewer than six	23781
each side	23799
the lateral funiculi , just ventral to the dorsal horns	23827
the lateral funiculi	23827
ventral to the dorsal horns	23854
the dorsal	23865
Axonal counts	23883
rostral to the injury site The number of Fluororuby-labeled dCST axons was counted in all groups at the cervical , upper and mid-thoracic levels	23897
rostral	23897
the injury site	23908
The number of Fluororuby-labeled dCST axons	23924
The number	23924
Fluororuby-labeled dCST axons	23938
all groups at the cervical , upper and mid-thoracic levels	23983
all groups	23983
the cervical , upper and mid-thoracic levels	23997
Fig. 2A	24042
the cervical , upper and mid-thoracic level	24055
there	24099
no statistically significant difference in the number of dCST fibres	24109
no statistically significant difference	24109
the number of dCST fibres	24152
the number	24152
dCST fibres	24166
all treatment groups	24181
a higher number of fibres in the groups that received ECs -LRB- encapsulated or injected -RRB-	24212
a higher number	24212
fibres in the groups that received ECs	24231
fibres	24231
the groups that received ECs	24241
the groups	24241
ECs	24266
the mid-thoracic level	24313
The control group that received CM-containing capsules together with CM injections	24337
The control group	24337
CM-containing capsules	24369
CM injections	24406
the least number of fibres	24424
the least number	24424
fibres	24444
86 F 20 fibres at the mid-thoracic level	24456
86 F 20 fibres	24456
the mid-thoracic level	24474
This value	24498
27 F 5 % of the number of fibres present at the cervical level -LRB- Fig. 2B -RRB-	24523
27 F	24523
the number of fibres present at the cervical level -LRB- Fig. 2B -RRB-	24534
the number	24534
fibres present at the cervical level -LRB- Fig. 2B -RRB-	24548
fibres present at the cervical level	24548
fibres	24548
the cervical level	24566
Fig. 2B	24586
the other control group which received only a CM-containing capsule	24608
the other control group	24608
only a CM-containing capsule	24647
this group	24677
additional acute injury	24698
multiple CM injections , hence the comparatively fewer fibres that were labeled	24727
multiple CM injections	24727
the comparatively fewer fibres that were labeled	24757
the comparatively fewer fibres	24757
The persistence of Fluororuby-labeled fibres at 5 weeks post-axotomy even in the absence of any cellular transplants	24807
The persistence	24807
Fluororuby-labeled fibres at 5 weeks post-axotomy even in the absence of any cellular transplants	24826
Fluororuby-labeled fibres	24826
5 weeks post-axotomy even in the absence of any cellular transplants	24855
5 weeks post-axotomy	24855
the absence of any cellular transplants	24884
the absence	24884
any cellular transplants	24899
a considerable proportion of dCST neurons	24938
a considerable proportion	24938
dCST neurons	24967
This	24995
it	25035
neurons	25062
chromatolysis and eventual cell death following traumatic injury -LRB- e.g. , Schwab and Bartholdi , 1996 -RRB-	25078
chromatolysis and eventual cell death	25078
traumatic injury -LRB- e.g. , Schwab and Bartholdi , 1996 -RRB-	25126
traumatic injury	25126
e.g. , Schwab and Bartholdi , 1996	25144
e.g.	25144
Schwab and Bartholdi	25150
1996	25172
Corticospinal tract fibres near the lesion site Dissection of the spinal cord at 5 weeks post-surgery	25179
Corticospinal tract fibres	25179
the lesion site Dissection of the spinal cord at 5 weeks post-surgery	25211
the lesion site Dissection	25211
the spinal cord at 5 weeks post-surgery	25241
the spinal cord	25241
5 weeks	25260
this time	25300
a layer of fibrous connective tissue	25311
a layer	25311
fibrous connective tissue	25322
the capsule , marked by a slight protrusion on the dorsal surface -LRB- Chuah and West , 2002 -RRB-	25363
the capsule	25363
a slight protrusion on the dorsal surface -LRB- Chuah and West , 2002 -RRB-	25386
a slight protrusion	25386
the dorsal surface -LRB- Chuah and West , 2002 -RRB-	25409
the dorsal surface	25409
Chuah and West	25429
2002	25445
Longitudinal sections	25452
the capsule	25488
the spinal cord	25525
the recovery period -LRB- Fig. 3 -RRB-	25548
the recovery period	25548
Fig. 3	25569
some animals	25584
some compression of the vCST	25608
some compression	25608
the vCST	25628
The cut edge of the dCST	25638
The cut edge	25638
the dCST	25654
a bright red fluorescent bundle with the axotomised edge directly apposed to the rostral tip of the capsule -LRB- Figs. 3 and 4A -RRB-	25678
a bright red fluorescent bundle	25678
the axotomised edge directly apposed to the rostral tip of the capsule -LRB- Figs. 3 and 4A -RRB-	25715
the axotomised edge	25715
the rostral tip of the capsule -LRB- Figs. 3 and 4A -RRB-	25755
the rostral tip	25755
the capsule -LRB- Figs. 3 and 4A -RRB-	25774
the capsule	25774
Figs. 3 and 4A	25787
Figs. 3	25787
4A	25799
both control and EC-treated rats	25807
both control	25807
EC-treated rats	25824
small numbers of nerve sprouts	25841
small numbers	25841
nerve sprouts	25858
the cut stump and sides of the dCST -LRB- Fig. 4B -RRB-	25901
the cut stump	25901
sides of the dCST -LRB- Fig. 4B -RRB-	25919
sides	25919
the dCST -LRB- Fig. 4B -RRB-	25928
the dCST	25928
Fig. 4B	25938
Small numbers of regenerating fibres	25948
Small numbers	25948
regenerating fibres	25965
10	25992
EC-treated rats	26012
the EC-encapsulated rats	26032
the regenerating fibres	26058
close association with the capsule , along its sides and caudally	26099
close association with the capsule	26099
close association	26099
the capsule	26122
its sides	26141
Figs. 4C , D and E	26173
Figs. 4C	26173
D and E	26183
These regenerating fibres	26193
axonal varicosities	26241
they	26265
a parallel direction , typical of dCST fibres	26309
a parallel direction	26309
typical of dCST fibres	26331
typical	26331
dCST fibres	26342
rats that received encapsulated ECs	26358
rats	26358
ECs	26390
some nerve fibres	26395
the caudal edge of the capsule -LRB- Fig. 4E -RRB- , a location and directional growth that are not associated with the normal trajectory of the dCST	26456
the caudal edge	26456
the capsule -LRB- Fig. 4E -RRB- , a location and directional growth that are not associated with the normal trajectory of the dCST	26475
the capsule	26475
Fig. 4E	26488
a location	26498
directional growth that are not associated with the normal trajectory of the dCST	26513
directional growth	26513
the normal trajectory of the dCST	26561
the normal trajectory	26561
the dCST	26586
contrast	26599
rats that had ECs injected directly into the spinal cord	26612
rats	26612
ECs injected directly into the spinal cord	26626
ECs	26626
the spinal cord	26653
fine nerve fibres	26670
the caudal tip of the CM-containing capsule -LRB- Fig. 4F -RRB-	26717
the caudal tip	26717
the CM-containing capsule -LRB- Fig. 4F -RRB-	26735
the CM-containing capsule	26735
Fig. 4F	26762
The longest of these caudally projecting fibres	26772
The longest	26772
these caudally projecting fibres	26787
these	26787
fibres	26813
10 mm distal to the caudal edge of the capsule	26839
10 mm	26839
the caudal edge of the capsule	26854
the caudal edge	26854
the capsule	26873
summary	26889
the observations	26898
there	26929
a few regenerating fibres from the sectioned dCST of rats which had received ECs -LRB- encapsulated or injected -RRB-	26940
a few regenerating fibres	26940
the sectioned dCST of rats which had received ECs -LRB- encapsulated or injected -RRB-	26971
the sectioned dCST	26971
rats which had received ECs -LRB- encapsulated or injected -RRB-	26993
rats	26993
ECs -LRB- encapsulated or injected -RRB-	27017
ECs	27017
regeneration	27058
large areas of necrosis , macrophages and tissue scarring	27096
large areas	27096
necrosis , macrophages and tissue scarring	27111
both control and EC-treated rats	27156
control	27161
EC-treated rats	27173
It	27190
some of the regenerating sprouts	27211
some	27211
the regenerating sprouts	27219
areas of brightly fluorescent cells	27274
areas	27274
brightly fluorescent cells	27283
macrophages -LRB- Fig. 4G -RRB-	27322
macrophages	27322
Fig. 4G	27335
The small number of regenerating fibres	27345
The small number	27345
regenerating fibres	27365
the finding	27404
there	27421
statistically significant differences in the number of dCST fibres rostral to the lesion	27436
statistically significant differences	27436
the number of dCST fibres rostral to the lesion	27477
the number	27477
dCST fibres rostral to the lesion	27491
dCST fibres rostral	27491
the lesion	27514
contrast to the dense , compact arrangement of fibres in the dCST	27529
contrast	27529
the dense , compact arrangement of fibres in the dCST	27541
the dense , compact arrangement	27541
fibres in the dCST	27575
fibres	27575
the dCST	27585
the brightly labeled vCST	27595
fibres that are distributed over a wide area in the ventral half of the spinal cord	27636
fibres	27636
a wide area in the ventral half of the spinal cord	27669
a wide area	27669
the ventral half of the spinal cord	27684
the ventral half	27684
the spinal cord	27704
a few animals that received encapsulated or injected ECs	27724
a few animals	27724
ECs	27777
branches from the vCST caudal to the lesion	27782
branches	27782
the vCST caudal to the lesion	27796
the vCST caudal	27796
the lesion	27815
the dorsal columns	27838
the space originally occupied	27878
the space	27878
the dCST -LRB- Fig. 4H -RRB-	27911
the dCST	27911
Fig. 4H	27921
These fibres	27931
new collateral sprouts	27949
they	27980
any axonal branches or terminations	28001
they	28040
the grey matter	28061
addition	28081
some EC-treated -LRB- injected or encapsulated -RRB- rats	28094
fibres in the dorsal	28163
fibres	28163
the dorsal	28173
columns , caudal to the lesion ,	28184
columns	28184
the lesion	28203
a network in the grey matter -LRB- Fig. 4I -RRB-	28247
a network	28247
the grey matter -LRB- Fig. 4I -RRB-	28260
the grey matter	28260
Fig. 4I	28277
This unusual axonal route	28287
Figs. 4H	28329
I	28342
animals from both control groups	28364
animals	28364
both control groups	28377
ECs injected directly into the spinal cord	28407
ECs	28407
the spinal cord	28434
Hoescht blue -LRB- Fig. 5A -RRB-	28485
Hoescht blue	28485
Fig. 5A	28499
there	28509
difficulty in localising the cells 5 weeks posttransplantation	28519
difficulty	28519
the cells 5 weeks posttransplantation	28544
cells	28548
5 weeks	28554
some animals	28586
ECs	28600
the injection site -LRB- Fig. 5B -RRB-	28618
the injection site	28618
Fig. 5B	28638
others	28657
very few ECs	28665
Fig. 5C	28692
Viable ECs	28702
the yellowish crystalloid autofluorescence of macrophages -LRB- Bunn et al. , 2002 ; Fig. 6 in Takami et al. , 2002 -RRB-	28741
the yellowish crystalloid autofluorescence	28741
macrophages -LRB- Bunn et al. , 2002 ; Fig. 6 in Takami et al. , 2002 -RRB-	28787
macrophages	28787
Bunn	28800
et al. , 2002 ; Fig. 6 in Takami et al. , 2002	28805
et al.	28805
2002 ; Fig. 6 in Takami et al.	28813
2002	28813
Fig. 6 in Takami et al.	28819
Fig. 6 in Takami	28819
Fig. 6	28819
Takami	28829
et al.	28836
2002	28844
their blue fluorescence under UV stimulation -LRB- Fig. 5B , inset	28853
their blue fluorescence under UV stimulation -LRB- Fig. 5B ,	28853
their blue fluorescence under UV stimulation	28853
their blue fluorescence	28853
UV stimulation	28883
Fig. 5B	28899
small areas where the two types of fluorescence overlapped	28919
small areas	28919
the two types of fluorescence	28937
the two types	28937
fluorescence	28954
it	28979
the fluorescence	28999
a consequence of macrophages having phagocytosed dead ECs	29025
a consequence	29025
macrophages	29042
dead ECs	29074
Axonal branching from the ventral corticospinal tract In addition to the number of labeled vCST fibres , axonal fibres observed to be clearly branching directly from the vCST -LRB- as shown in Fig. 4H -RRB-	29084
Axonal branching from the ventral corticospinal tract In addition to the number of labeled vCST fibres	29084
Axonal	29084
the ventral corticospinal tract	29106
addition	29141
the number of labeled vCST fibres	29153
the number	29153
labeled vCST fibres	29167
axonal fibres observed to be clearly branching directly from the vCST -LRB- as shown in Fig. 4H -RRB-	29188
axonal fibres observed to be clearly branching directly from the vCST	29188
axonal fibres	29188
the vCST	29249
Fig. 4H	29271
Initial overview	29299
there	29328
variability in the proportion of labeled fibres in the vCST	29338
variability	29338
the proportion of labeled fibres in the vCST	29353
the proportion	29353
labeled fibres in the vCST	29371
labeled fibres	29371
the vCST	29389
This	29399
part to the fact	29414
part	29414
the fact	29422
the total number of fibres in this tract	29436
the total number	29436
fibres in this tract	29456
fibres	29456
this tract	29466
that of the dCST , about 19 % and probably	29503
that of the dCST	29503
that	29503
the dCST	29511
19 %	29527
the motor neurons	29557
a wider cortical region	29594
the data	29632
the number of axonal branches and terminations	29642
the number	29642
axonal branches and terminations	29656
a ratio of the number of labeled vCST fibres -LRB- Figs. 6A and B -RRB-	29706
a ratio	29706
the number of labeled vCST fibres -LRB- Figs. 6A and B -RRB-	29717
the number	29717
labeled vCST fibres -LRB- Figs. 6A and B -RRB-	29731
labeled vCST fibres	29731
Figs. 6A and B	29752
Figs. 6A	29752
B	29765
ANOVA analysis of the data	29769
ANOVA analysis	29769
the data	29787
there	29808
a statistically significant difference among treatment groups -LRB- P = 0.01 -RRB-	29818
a statistically significant difference	29818
treatment groups -LRB- P = 0.01 -RRB-	29863
treatment groups	29863
P	29882
0.01	29886
The two control groups -LRB- lesion with transplantation of CM-filled capsule ; lesion with transplantation of CM-filled capsule , and injections of CM -RRB-	29893
The two control groups	29893
lesion with transplantation of CM-filled capsule ; lesion with transplantation of CM-filled capsule , and injections of CM	29917
lesion	29917
transplantation of CM-filled capsule ; lesion with transplantation of CM-filled capsule , and injections of CM	29929
transplantation of CM-filled capsule	29929
transplantation	29929
CM-filled capsule	29948
lesion with transplantation of CM-filled capsule	29967
lesion	29967
transplantation of CM-filled capsule	29979
transplantation	29979
CM-filled capsule	29998
injections of CM	30021
injections	30021
CM	30035
markedly lower ratios of branches	30043
markedly lower ratios	30043
branches	30068
fibres	30080
the unlesioned group	30101
This	30123
the fact	30151
the ventrally displaced capsule	30165
some of the branches of the vCST	30205
some	30205
the branches of the vCST	30213
the branches	30213
the vCST	30229
the control group that received injections of CM	30245
the control group	30245
injections of CM	30277
injections	30277
CM	30291
additional acute injury	30304
Pair-wise comparison	30329
spinal cords that had ECs injected into the vicinity of the lesion	30362
spinal cords	30362
ECs injected into the vicinity of the lesion	30384
ECs	30384
the vicinity of the lesion	30402
the vicinity	30402
the lesion	30418
significantly more branches	30433
intact vCST fibres	30466
the corresponding control animals -LRB- P = 0.003 -RRB-	30499
the corresponding control animals	30499
P	30535
0.003	30539
there	30562
a trend for the spinal cords that had encapsulated ECs to have more axonal branches than those which received CM containing capsules -LRB- P = 0.07 -RRB-	30572
a trend	30572
the spinal cords that had encapsulated ECs to have more axonal branches than those which received CM containing capsules -LRB- P = 0.07 -RRB-	30584
the spinal cords	30584
ECs	30623
more axonal branches	30635
those which received CM containing capsules	30661
those	30661
CM	30682
capsules	30696
P	30706
0.07	30710
No significant difference in axonal branching	30717
No significant difference	30717
axonal branching	30746
axonal	30746
a comparison between the EC-injected and EC-encapsulated groups -LRB- P = 1.00 -RRB-	30779
a comparison	30779
the EC-injected and EC-encapsulated groups -LRB- P = 1.00 -RRB-	30800
the EC-injected and EC-encapsulated groups	30800
P	30845
1.00	30849
The ratio of fibre terminations in the grey matter to vCST fibres	30856
The ratio	30856
fibre terminations in the grey matter to vCST fibres	30869
fibre terminations	30869
the grey matter to vCST fibres	30891
the grey matter	30891
vCST fibres	30910
treatment groups -LRB- Fig. 6B -RRB-	30943
treatment groups	30943
Fig. 6B	30961
it	30980
there	31014
more fibre terminations in the two groups that received ECs	31025
more fibre terminations	31025
the two groups	31052
ECs	31081
the group that had ECs injected into the vicinity of the lesion	31101
the group	31101
ECs injected into the vicinity of the lesion	31120
ECs	31120
the vicinity of the lesion	31138
the vicinity	31138
the lesion	31154
a mean value of 9.2 ± 2.7 terminations per fibre	31169
a mean value	31169
9.2 ± 2.7 terminations per fibre	31185
9.2 ± 2.7 terminations	31185
fibre	31212
its control which had only 3.1 ± 0.7 -LRB- P = 0.075 -RRB-	31232
its control	31232
only 3.1	31254
0.7	31265
P	31270
0.075	31274
Discussion	31283
We	31294
the effect of encapsulated versus injected ECs on collateral axonal sprouting and regeneration in the injured spinal cord	31311
the effect of encapsulated	31311
the effect	31311
injected ECs on collateral axonal sprouting	31345
injected ECs	31345
collateral axonal sprouting	31361
collateral axonal	31361
regeneration in the injured spinal cord	31393
regeneration	31393
the injured spinal cord	31409
We	31434
the first time that collateral axonal branching from the intact vCST is significantly increased in the presence of ECs	31452
the first time	31452
collateral axonal branching from the intact vCST	31472
collateral axonal	31472
the intact vCST	31505
the presence of ECs	31551
the presence	31551
ECs	31567
A small number of regenerating fibres	31572
A small number	31572
regenerating fibres	31590
the two groups of rats which received ECs -LRB- encapsulated and injected -RRB- , consistent with results that have been reported previously by other research groups -LRB- Ramon-Cueto et al. , 2000 ; Takami et al. , 2002 -RRB-	31626
the two groups	31626
rats which received ECs -LRB- encapsulated and injected -RRB- , consistent with results that have been reported previously by other research groups -LRB- Ramon-Cueto et al. , 2000 ; Takami et al. , 2002 -RRB-	31644
rats	31644
ECs -LRB- encapsulated and injected -RRB-	31664
ECs	31664
results that have been reported previously by other research groups	31713
results	31713
other research groups	31759
Ramon-Cueto	31782
et al. , 2000 ; Takami et al. , 2002	31794
et al.	31794
2000 ; Takami et al.	31802
2000	31802
Takami et al.	31808
Takami	31808
et al.	31815
2002	31823
Response of vCST to injury in the dorsal columns	31830
Response	31830
vCST to injury in the dorsal columns	31842
vCST	31842
injury in the dorsal columns	31850
injury	31850
the dorsal columns	31860
this study , ECs transplanted into the spinal cord following injury to dCST	31882
this study	31882
ECs transplanted into the spinal cord following injury to dCST	31894
ECs	31894
the spinal cord following injury to dCST	31916
the spinal cord	31916
injury to dCST	31942
injury	31942
dCST	31952
increased collateral branches from the vCST	31969
increased collateral branches	31969
the vCST	32004
These new branches	32014
the grey matter	32054
the original path of the dCST	32110
the original path	32110
the dCST	32131
The response of vCST to injury in the dCST	32141
The response	32141
vCST to injury in the dCST	32157
vCST	32157
injury in the dCST	32165
injury	32165
the dCST	32175
ECtransplantation studies	32217
this observation of collateral sprouting	32248
this observation	32248
collateral sprouting	32268
collateral	32268
the accurate interpretation of results	32318
the accurate interpretation	32318
results	32349
nerve fibres	32365
their origin	32392
their mere presence in the dorsal column caudal to a dCST lesion	32406
their mere presence	32406
the dorsal column caudal to a dCST lesion	32429
the dorsal column caudal	32429
a dCST lesion	32457
regenerating fibres	32503
It	32524
previous studies which reported the presence of regenerating dCST fibres following EC transplantation	32544
previous studies	32544
the presence of regenerating dCST fibres following EC transplantation	32576
the presence	32576
dCST fibres following EC transplantation	32605
dCST fibres	32605
EC transplantation	32627
axons	32666
vCST in their observations	32677
vCST	32677
their observations	32685
Li et al. , 1998 ; Nash et al. , 2002 ; Takami et al. , 2002	32705
Li	32705
et al. , 1998 ; Nash et al. , 2002 ; Takami et al. , 2002	32708
et al. , 1998	32708
et al.	32708
1998	32716
Nash et al. , 2002	32722
Nash	32722
et al. , 2002	32727
et al.	32727
2002	32735
Takami et al. , 2002	32741
Takami	32741
et al. , 2002	32748
et al.	32748
2002	32756
Li et al. -LRB- 1998 -RRB-	32763
Li et al.	32763
Li	32763
et al.	32766
1998	32774
CST axons	32788
biotin dextran	32811
the medullary pyramid or the entire contralateral sensorimotor cortex	32838
the medullary pyramid	32838
the entire contralateral sensorimotor cortex	32863
Such an extensive injection	32909
the vCST	32968
a recent study in which the thoracic spinal cord was contused	32981
a recent study	32981
the thoracic spinal cord	33005
a quantitative analysis	33044
the number of fibres in the dorsal column rostral to and near the lesion -LRB- Takami et al. , 2002 -RRB-	33080
the number	33080
fibres in the dorsal column rostral to and near the lesion -LRB- Takami et al. , 2002 -RRB-	33094
fibres	33094
the dorsal column rostral to and near the lesion -LRB- Takami et al. , 2002 -RRB-	33104
the dorsal column rostral	33104
the lesion	33142
Takami	33154
et al. , 2002	33161
et al.	33161
2002	33169
the authors	33185
the presence of the fibres near the lesion	33211
the presence	33211
the fibres near the lesion	33227
the fibres	33227
the lesion	33243
regeneration	33271
they	33285
some	33309
the spared vCST	33340
a total transection of the spinal cord	33364
a total transection	33364
the spinal cord	33387
the neuroanatomical contribution of collateral sprouting to fibres	33417
the neuroanatomical contribution	33417
collateral sprouting to fibres	33453
collateral	33453
fibres	33477
the lesion can not be entirely discounted	33494
the lesion	33494
the contribution of collateral sprouting from descending motor tracts to functional recovery	33547
the contribution	33547
collateral sprouting from descending motor tracts to functional recovery	33567
collateral	33567
motor tracts	33604
functional recovery	33620
Murray and Goldberger	33670
1974	33693
An early report	33700
mid-brain derived tracts following thoracic spinal cord sectioning -LRB- Prendergast and Misantone , 1980 -RRB-	33753
mid-brain	33753
tracts following thoracic spinal cord sectioning -LRB- Prendergast and Misantone , 1980 -RRB-	33771
tracts	33771
thoracic spinal cord sectioning -LRB- Prendergast and Misantone , 1980 -RRB-	33788
thoracic spinal cord sectioning	33788
Prendergast and Misantone , 1980	33821
Prendergast and Misantone	33821
1980	33848
the sparing of a few fibres in the ventral funiculus of the rat spinal cord	33870
the sparing	33870
a few fibres in the ventral funiculus of the rat spinal cord	33885
a few fibres	33885
the ventral funiculus of the rat spinal cord	33901
the ventral funiculus	33901
the rat spinal cord	33926
abilities	33995
locomotion -LRB- Schucht et al. , 2002 -RRB-	34008
locomotion	34008
Schucht	34020
et al. , 2002	34028
et al.	34028
2002	34036
A study on adult rats	34043
A study	34043
adult rats	34054
spontaneous sprouting from the vCST following lesion of the dCST	34079
spontaneous	34079
the vCST following lesion of the dCST	34106
the vCST	34106
lesion of the dCST	34125
lesion	34125
the dCST	34135
the rats ' ability to retrieve food pellets	34160
the rats '	34160
food pellets	34190
the vCST	34207
functional recovery	34242
Weidner et al. , 2001	34277
Weidner	34277
et al.	34285
2001	34293
Influence of ECs on the response of the vCST	34300
Influence	34300
ECs on the response of the vCST	34313
ECs	34313
the response of the vCST	34320
the response	34320
the vCST	34336
a statistically significant increase in collateral sprouting	34354
a statistically significant increase	34354
collateral sprouting	34394
collateral	34394
rats that had ECs injected directly into the injury site , those that received encapsulated ECs	34436
rats	34436
ECs injected directly into the injury site , those that received encapsulated ECs	34450
ECs	34450
the injury site , those that received encapsulated ECs	34477
the injury site	34477
those that received encapsulated ECs	34494
those	34494
ECs	34527
a trend for increased branching -LRB- P = 0.07 -RRB-	34544
a trend	34544
increased branching -LRB- P = 0.07 -RRB-	34556
increased branching	34556
P	34577
0.07	34581
the group that received EC injections was compared with the one that received	34593
the group	34593
EC injections	34617
the one that received	34649
the one	34649
ECs	34684
there	34689
no clear statistically significant difference between them -LRB- P = 1.00 -RRB-	34699
no clear statistically significant difference	34699
them	34753
P	34759
1.00	34763
The promotion of collateral sprouting by diffusible growth factors	34770
The promotion	34770
collateral sprouting by diffusible growth factors	34787
collateral	34787
diffusible growth factors	34811
evidence	34853
numerous studies	34867
different types of neurons -LRB- Cohen-Cory and Fraser , 1995 ; Gallo and Letourneau , 1998 ; He et al. , 1992 ; Schnell et al. , 1994 -RRB-	34887
different types	34887
neurons -LRB- Cohen-Cory and Fraser , 1995 ; Gallo and Letourneau , 1998 ; He et al. , 1992 ; Schnell et al. , 1994 -RRB-	34906
neurons	34906
Cohen-Cory and Fraser	34915
Cohen-Cory	34915
Fraser	34930
1995 ; Gallo and Letourneau , 1998 ; He et al. , 1992 ; Schnell et al. , 1994	34938
1995	34938
Gallo and Letourneau , 1998 ; He et al. , 1992 ; Schnell et al. , 1994	34944
Gallo and Letourneau , 1998	34944
Gallo and Letourneau	34944
1998	34966
He et al. , 1992	34972
He	34972
et al. , 1992	34975
et al.	34975
1992	34983
Schnell et al. , 1994	34989
Schnell	34989
et al. , 1994	34997
et al.	34997
1994	35005
The peculiar course of a few regenerating fibres closely enveloping the caudal end of a capsule containing ECs , as shown in Fig. 4E ,	35012
The peculiar course	35012
a few regenerating fibres closely enveloping the caudal end of a capsule containing ECs	35035
a few regenerating fibres	35035
the caudal end of a capsule containing ECs	35080
the caudal end	35080
a capsule containing ECs	35098
a capsule	35098
ECs	35119
Fig. 4E	35136
an affinity between the nerve fibres and capsule	35162
an affinity	35162
the nerve fibres and capsule	35182
the nerve fibres	35182
capsule	35203
diffusible factors	35220
this behaviour	35264
future experiments	35308
Other controlling mechanisms	35328
our observations	35375
The fact that only the group that received EC-injections demonstrated a statistically significant increase in the ratio of branches when compared with their corresponding control group suggests that injected ECs	35393
The fact	35393
only the group that received EC-injections demonstrated a statistically significant increase in the ratio of branches when compared with their corresponding control group	35407
only the group	35407
EC-injections	35436
a statistically significant increase	35463
the ratio of branches	35503
the ratio	35503
branches	35516
their corresponding control group	35544
ECs	35601
the inflammatory response	35624
the injury site	35653
One possibility	35670
the expression of inhibitory molecules such as chondroitin sulphate proteoglycan	35704
the expression	35704
inhibitory molecules such as chondroitin sulphate proteoglycan	35722
inhibitory molecules	35722
chondroitin sulphate proteoglycan	35751
Developmental studies	35786
an increase in the polysialic acid level of the neural cell adhesion molecule -LRB- NCAM -RRB- on CST axons	35824
an increase	35824
the polysialic acid level of the neural cell adhesion molecule -LRB- NCAM -RRB- on CST axons	35839
the polysialic acid level	35839
the neural cell adhesion molecule -LRB- NCAM -RRB- on CST axons	35868
the neural cell adhesion molecule -LRB- NCAM -RRB-	35868
the neural cell adhesion molecule	35868
NCAM	35903
CST axons	35912
the initiation of collateral branching -LRB- Daston et al. , 1996 ; Joosten et al. , 1996 -RRB-	35937
the initiation	35937
collateral branching	35955
collateral	35955
Daston	35977
et al. , 1996 ; Joosten et al. , 1996	35984
et al.	35984
1996 ; Joosten et al.	35992
1996	35992
Joosten et al.	35998
Joosten	35998
et al.	36006
1996	36014
The cell adhesion molecule NCAM	36021
ECs both in vivo	36069
ECs both	36069
ECs	36069
vivo	36081
Chuah and Au , 1993 ; Miragall et al. , 1988	36100
Chuah and Au	36100
1993 ; Miragall et al.	36114
1993	36114
Miragall et al.	36120
Miragall	36120
et al.	36129
1988	36137
It	36144
our study	36167
NCAM expressed by encapsulated ECs	36178
NCAM	36178
ECs	36209
the capsule	36233
hence lesioned fibres	36250
stimulation	36301
the less exuberant collateral branching	36334
the less exuberant collateral	36334
Preliminary scanning electron microscopy of encapsulated ECs retrieved from the spinal cord	36375
Preliminary scanning electron microscopy	36375
ECs	36432
the spinal cord	36451
ECs	36478
a mucoid material	36511
extracellular matrix	36555
the capsule	36598
regenerating fibres	36636
Survival of ECs in the spinal cord	36657
Survival	36657
ECs in the spinal cord	36669
ECs	36669
the spinal cord	36676
the exact extent of EC survival in the injured spinal cord	36701
the exact extent	36701
EC survival in the injured spinal cord	36721
EC survival	36721
the injured spinal cord	36736
several studies -LRB- Nash et al. , 2002 ; Ramon-Cueto et al. , 1998 , 2000 -RRB-	36786
several studies	36786
Nash et al. , 2002 ; Ramon-Cueto et al. , 1998 , 2000	36803
Nash et al.	36803
Nash	36803
et al.	36808
2002 ; Ramon-Cueto et al.	36816
2002	36816
Ramon-Cueto et al.	36822
Ramon-Cueto	36822
et al.	36834
1998 , 2000	36842
1998	36842
2000	36848
ECs	36870
the spinal cord over a long period , up to 8 months after implantation -LRB- Ramon-Cueto et al. , 2000 -RRB-	36897
the spinal cord	36897
a long period , up to 8 months after implantation -LRB- Ramon-Cueto et al. , 2000 -RRB-	36918
a long period	36918
to 8 months	36936
implantation	36954
Ramon-Cueto et al. , 2000	36968
Ramon-Cueto	36968
et al.	36980
2000	36988
this study	36998
it	37010
some ECs	37030
the spinal cord	37057
5 weeks	37076
it	37112
most of them	37132
most	37132
them	37140
macrophages	37170
our study	37186
autofluorescence of macrophages	37197
autofluorescence	37197
macrophages	37217
Hoechstlabeled ECs	37265
most instances	37293
these two types of fluorescence	37308
these two types	37308
fluorescence	37327
DeLucia et al. -LRB- 2003 -RRB-	37372
DeLucia et al.	37372
DeLucia	37372
et al.	37380
2003	37388
a cell line of Hoescht-labeled ECs	37406
a cell line	37406
Hoescht-labeled ECs	37421
macrophages or microglia 2 weeks following transplantation	37485
macrophages or microglia	37485
2 weeks	37510
transplantation	37528
recent experiments on encapsulated ECs in the spinal cord	37548
recent experiments	37548
ECs in the spinal cord	37583
ECs	37583
the spinal cord	37590
we	37607
the ECs	37626
the capsules	37645
growth-promoting molecules such as neuregulins -LRB- Woodhall et al. , 2003 -RRB-	37682
growth-promoting molecules	37682
neuregulins -LRB- Woodhall et al. , 2003 -RRB-	37717
neuregulins	37717
Woodhall	37730
et al. , 2003	37739
et al.	37739
2003	37747
Real time	37754
quantitative RT-PCR performed on encapsulated ECs retrieved from the spinal cord	37764
quantitative RT-PCR	37764
ECs	37810
the spinal cord	37829
the expression profile of the various isoforms of neuregulins	37857
the expression profile	37857
the various isoforms of neuregulins	37883
the various isoforms	37883
neuregulins	37907
response	37930
the novel CNS environment	37942
One possible reason why it was difficult to localize ECs injected into the spinal cord	37969
it	37993
ECs injected into the spinal cord	38022
ECs	38022
the spinal cord	38040
ECs	38068
hence the fluorescent label	38102
Preliminary experiments in our laboratory	38162
Preliminary experiments	38162
our laboratory	38189
ECs	38214
increased proliferation	38226
spinal cord tissue	38266
Another reason	38286
the conditions influencing migration of ECs in the spinal cord	38309
the conditions	38309
migration of ECs in the spinal cord	38336
migration	38336
ECs in the spinal cord	38349
ECs	38349
the spinal cord	38356
It	38400
ECs	38426
the vicinity of the lesion	38466
the vicinity	38466
the lesion	38482
they	38510
signals from injured neurons -LRB- Boruch et al. , 2002 -RRB-	38536
signals	38536
injured neurons -LRB- Boruch et al. , 2002 -RRB-	38549
injured neurons	38549
Boruch	38566
et al. , 2002	38573
et al.	38573
2002	38581
a study in which the medial longitudinal fasciculus was transected	38600
a study	38600
the medial longitudinal fasciculus	38617
ECs	38668
the lesion -LRB- Gudino - Cabrera et al. , 1999 -RRB-	38706
the lesion	38706
Gudino	38718
Cabrera et al. , 1999	38726
Cabrera	38726
et al.	38734
1999	38742
The resolution of the fate and migratory behaviour of ECs in the spinal cord	38749
The resolution	38749
the fate and migratory behaviour of ECs in the spinal cord	38767
the fate and migratory behaviour	38767
ECs in the spinal cord	38803
ECs	38803
the spinal cord	38810
they	38855
a clinically relevant therapeutic agent	38885
Acknowledgments This work	38927
Acknowledgments	38927
This work	38943
the Motor Accident and Insurance Board -LRB- MAIB -RRB- of Tasmania , International Institute for Research in Paraplegia and the National Health and Medical Research Council	38967
the Motor Accident and Insurance Board -LRB- MAIB -RRB- of Tasmania	38967
the Motor Accident and Insurance Board -LRB- MAIB -RRB-	38967
the Motor Accident and Insurance Board	38967
MAIB	39007
Tasmania	39016
International Institute for Research in Paraplegia	39026
International Institute	39026
Research in Paraplegia	39054
Research	39054
Paraplegia	39066
the National Health and Medical Research Council	39081
the National Health	39081
Medical Research Council	39105
We	39131
Dr Jim Stankovich for advice on statistical analysis	39140
Dr Jim Stankovich	39140
advice on statistical analysis	39162
advice	39162
statistical analysis	39172
References Boruch , A.V. , Conners , J.J. , Pipitone , M. , Deadwyler , G. , Storer , P.D. , Devries , G.H. , Jones , K.J. , 2002 .	39195
References	39195
Boruch , A.V. , Conners , J.J. , Pipitone , M. , Deadwyler , G. , Storer , P.D. , Devries , G.H. , Jones , K.J. , 2002	39206
Boruch , A.V. , Conners , J.J. , Pipitone , M. , Deadwyler , G. , Storer , P.D. , Devries , G.H. , Jones , K.J. ,	39206
2002	39306
Neurotrophic and migratory properties of an olfactory ensheathing cell line .	39312
Neurotrophic and migratory properties	39312
an olfactory ensheathing cell line	39353
Glia 33 , 225 -- 229 .	39389
Glia 33	39389
225 -- 229	39398
Bunn , H.J. , Woltmann , G. , Grigg , J. , 2002 .	39407
Bunn , H.J. , Woltmann , G. , Grigg , J.	39407
2002	39444
Applicability of laser scanning cytometry to study paediatric alveolar macrophages .	39450
Applicability	39450
laser scanning cytometry	39467
paediatric alveolar macrophages	39501
Eur	39534
Respir	39539
J. 20 , 1437 -- 1443 .	39547
J. 20 , 1437	39547
1443	39560
Chuah , M.I. , Au , C. , 1993 .	39566
Chuah , M.I. , Au , C.	39566
1993	39587
Cultures of ensheathing cells from neonatal rat olfactory bulbs .	39593
Cultures	39593
ensheathing cells	39605
neonatal rat olfactory bulbs	39628
neonatal rat	39628
olfactory bulbs	39641
Brain Res .	39658
Brain	39658
Res	39664
601 , 213 -- 220 .	39669
601	39669
213 -- 220	39674
Chuah , M.I. , Au , C. , 1994 .	39684
Chuah , M.I. , Au , C.	39684
1994	39705
Olfactory cell cultures on ensheathing cell monolayers .	39711
Olfactory cell cultures	39711
ensheathing cell monolayers	39738
Chem	39767
Senses 19 , 25 -- 34 .	39773
Senses 19	39773
25 -- 34	39784
Chuah , M.I. , Teague , R. , 1999 .	39792
Chuah , M.I. , Teague , R.	39792
1999	39817
Basic fibroblast growth factor in the primary olfactory pathway : mitogenic effect on ensheathing cells .	39823
Basic fibroblast growth factor in the primary olfactory pathway	39823
Basic fibroblast growth factor	39823
the primary olfactory pathway	39857
mitogenic effect on ensheathing cells	39888
mitogenic effect	39888
ensheathing cells	39908
Neuroscience 88 , 1043 -- 1050 .	39927
Neuroscience 88 , 1043	39927
1050	39949
Chuah , M.I. , West , A.K. , 2002 .	39955
Chuah , M.I. , West , A.K.	39955
2002	39980
Cellular and molecular biology of ensheathing cells .	39986
Cellular and molecular biology	39986
ensheathing cells	40020
Microsc	40039
Res	40048
Tech	40053
58 , 216 -- 227 .	40059
58	40059
216 -- 227	40063
Chuah , M.I. , David , S. , Blaschuk , O. , 1991 .	40073
Chuah , M.I. , David , S. , Blaschuk , O.	40073
1991	40111
Differentiation and survival of rat	40117
Differentiation and survival	40117
rat	40149
olfactory epithelial neurons	40153
cell culture	40197
Dev .	40211
Brain Res .	40216
Brain	40216
Res	40222
60 , 123 -- 132 .	40227
60	40227
123 -- 132	40231
Chuah , M.I. , Cossins , J.-M. , Woodhall , E. , Tennant , R. , Nash , G. , West , A.K. , 2000 .	40241
Chuah , M.I. , Cossins , J.-M. , Woodhall , E. , Tennant , R. , Nash , G. , West , A.K.	40241
2000	40319
Glial Growth Factor 2	40325
Glial Growth Factor	40325
2	40345
proliferation and structural changes in ensheathing cells	40355
proliferation and structural changes	40355
ensheathing cells	40395
Brain Res .	40414
Brain	40414
Res	40420
857 , 265 -- 274 .	40425
857	40425
265 -- 274	40430
Cohen-Cory , S. , Fraser , S.E. , 1995 .	40440
Cohen-Cory , S. , Fraser , S.E.	40440
1995	40470
Effects of brain-derived neurotrophic factor on optic axon branching and remodelling in vivo .	40476
Effects of brain-derived neurotrophic factor on optic axon	40476
Effects	40476
brain-derived neurotrophic factor on optic axon	40487
brain-derived neurotrophic factor	40487
optic axon	40524
Nature 378 , 192 -- 196 .	40570
Nature 378 , 192	40570
196	40587
Daston , M.M. , Bastmeyer , M. , Rutishauser , U. , O'Leary , D.D.M. , 1996 .	40592
Daston , M.M. , Bastmeyer , M. , Rutishauser , U. , O'Leary , D.D.M.	40592
1996	40655
Spatially restricted increase in polysialic acid	40661
Spatially restricted increase	40661
polysialic acid	40694
corticospinal axon	40719
recognition and innervation	40766
J. Neurosci .	40795
16 , 5497 -- 5499 .	40808
16	40808
5497 -- 5499	40812
DeLucia , T.A. , Conners , J.J. , Brown , T.J. , Cronin , C.M. , Khan , T. , Jones , K.J. , 2003 .	40823
DeLucia , T.A. , Conners , J.J. , Brown , T.J. , Cronin , C.M. , Khan , T. , Jones , K.J.	40823
2003	40903
Use of a cell line to investigate olfactory ensheathing	40909
Use	40909
a cell line	40916
olfactory ensheathing	40943
axonal regeneration	40978
Anat	40999
Rec .	41005
271B , 61 -- 70 .	41010
271B	41010
61 -- 70	41016
Emery , E. , Aldana , P. , Bunge , M.B. , Puckett , W. , Srinivasan , A. , Keane , R.W. , Bethea , J. , Levi , A.D. , 1998 .	41024
Emery , E. , Aldana , P. , Bunge , M.B. , Puckett , W. , Srinivasan	41024
A.	41085
Keane , R.W. , Bethea , J. , Levi , A.D.	41089
1998	41126
Apoptosis after traumatic human spinal cord injury .	41132
Apoptosis	41132
traumatic human spinal cord injury	41148
J. Neurosurg .	41184
89 , 911 -- 920 .	41198
89	41198
911 -- 920	41202
Fawcett , J.W. , Asher , R.A. , 1999 .	41212
Fawcett , J.W. , Asher , R.A.	41212
1999	41240
The glial scar and central nervous system repair .	41246
The glial scar and central nervous system repair	41246
The glial scar	41246
central nervous system repair	41265
Brain Res .	41296
Brain	41296
Res	41302
Bull .	41307
49 , 377 -- 391 .	41313
49	41313
377 -- 391	41317
Gallo , G. , Letourneau , P.C. , 1998 .	41327
Gallo , G. , Letourneau , P.C.	41327
1998	41356
Localised sources of neurotrophins	41362
Localised sources	41362
neurotrophins	41383
axon collateral sprouting	41406
axon collateral	41406
J. Neurosci .	41433
18 , 5403 -- 5414 .	41446
18	41446
5403 -- 5414	41450
Gudino-Cabrera , G. , Pastor , A.M. , de la Cruz , R.R. , Delgado-Garcia , J.M. , Nieto-Sampedro , M. , 1999 .	41462
Gudino-Cabrera , G. , Pastor , A.M.	41462
Cruz , R.R. , Delgado-Garcia , J.M. , Nieto-Sampedro , M. , 1999	41502
Cruz , R.R. , Delgado-Garcia , J.M. , Nieto-Sampedro , M.	41502
1999	41556
Limits to the capacity of transplants of olfactory glia to promote axonal regrowth in the CNS .	41562
Limits	41562
the capacity of transplants of olfactory glia	41572
the capacity	41572
transplants of olfactory glia	41588
transplants	41588
olfactory glia	41603
axonal regrowth	41629
the CNS	41648
NeuroReport 11 , 467 -- 471 .	41657
NeuroReport 11 , 467	41657
471	41678
He , Y. , Yao , Z. , Gu , Y. , Kuang , G. , Chen , Y. , 1992 .	41683
He	41683
Y. , Yao , Z. , Gu , Y. , Kuang , G. , Chen , Y. , 1992	41687
Y. , Yao , Z. , Gu , Y. , Kuang , G. , Chen , Y. ,	41687
1992	41729
Nerve growth factor	41735
collateral sprouting of cholinergic fibres in the septohippocampal cholinergic system of aged rats with fimbria transection	41764
collateral	41764
cholinergic fibres in the septohippocampal cholinergic system of aged rats	41788
cholinergic fibres	41788
the septohippocampal cholinergic system of aged rats	41810
the septohippocampal cholinergic system	41810
aged rats	41853
fimbria transection	41868
Brain Res .	41889
Brain	41889
Res	41895
586 , 27 -- 35 .	41900
586	41900
27 -- 35	41905
Henderson , C. , 1989 .	41913
Henderson , C.	41913
1989	41928
Aminoalkylsilane : an inexpensive simple preparation for slide adhesion .	41934
Aminoalkylsilane	41934
an inexpensive simple preparation for slide adhesion	41952
an inexpensive simple preparation	41952
slide adhesion	41990
J. Histotechnol .	42006
12 , 123 -- 124 .	42023
12	42023
123 -- 124	42027
Imaizumi , T. , Lankford , K.L. , Waxman , S.G. , Greer , C.A. , Kocsis , J.D. , 1998 .	42037
Imaizumi , T. , Lankford , K.L. , Waxman , S.G. , Greer , C.A. , Kocsis , J.D.	42037
1998	42108
olfactory ensheathing cells	42127
remyelinate	42155
axonal conduction	42179
the demyelinated dorsal columns of the rat spinal cord	42200
the	42200
dorsal columns of the rat spinal cord	42217
dorsal columns	42217
the rat spinal cord	42235
J. Neurosci .	42256
18 , 6176 -- 6185 .	42269
18	42269
6176 -- 6185	42273
Joosten , E.A.J. , Reshilov , L.N. , Gispen , W.H. , Bar , P.R. , 1996 .	42284
Joosten , E.A.J. , Reshilov , L.N. , Gispen , W.H. , Bar ,	42284
P.R. , 1996	42336
P.R.	42336
1996	42342
Embryonic form of N-CAM and development of the rat corticospinal tract : immuno - electron microscopical localization during spinal white matter ingrowth .	42348
Embryonic form of N-CAM and development of the rat corticospinal tract	42348
Embryonic form	42348
N-CAM and development	42366
the rat corticospinal tract	42391
immuno - electron microscopical localization during spinal white matter ingrowth	42420
immuno	42420
electron microscopical localization during spinal white matter ingrowth	42428
electron microscopical localization	42428
spinal white matter ingrowth	42471
Dev .	42501
Brain Res .	42506
Brain	42506
Res	42512
94 , 99 -- 105 .	42517
94	42517
99 -- 105	42521
Li , X.G. , Florence , S.L. , Kaas , J.H. , 1990 .	42530
Li , X.G. , Florence , S.L. , Kaas , J.H.	42530
1990	42568
Areal distributions of cortical neurons projecting to different levels of the caudal brain stem and spinal cord in rats .	42574
Areal distributions of cortical neurons	42574
Areal distributions	42574
cortical neurons	42597
different levels of the caudal brain stem and spinal cord in rats	42628
different levels of the caudal brain stem	42628
different levels	42628
the caudal brain stem	42648
spinal cord in rats	42674
spinal cord	42674
rats	42689
Somatosens .	42695
Motor Res .	42707
7 , 315 -- 335 .	42718
7	42718
315 -- 335	42721
Li , Y. , Field , P.M. , Raisman , G. , 1997 .	42730
Li , Y. , Field , P.M. , Raisman , G.	42730
1997	42764
Repair of adult rat corticospinal tract by transplants of olfactory ensheathing cells .	42770
Repair	42770
adult rat corticospinal tract	42780
transplants of olfactory ensheathing cells	42813
transplants	42813
olfactory ensheathing cells	42828
Science 277 , 2000 -- 2002 .	42857
Science 277 , 2000	42857
2002	42876
Li , Y.L. , Field , P.M. , Raisman , G. , 1998 .	42882
Li , Y.L. , Field , P.M. , Raisman , G.	42882
1998	42918
Regeneration of adult rat corticospinal axons	42924
Regeneration	42924
adult rat corticospinal axons	42940
adult rat	42940
corticospinal axons	42950
transplanted olfactory ensheathing cells	42981
transplanted olfactory ensheathing	42981
cells	43016
J. Neurosci .	43023
18 , 10514 -- 10524 .	43036
18	43036
10514 -- 10524	43040
Liang , L. , Moret , V. , Wiesendanger , M. , Rouiller , E. , 1991 .	43054
Liang , L. , Moret , V. , Wiesendanger , M. , Rouiller , E.	43054
1991	43108
Corticomotoneuronal connections in the rat : evidence from double-labeling of motoneurons and corticospinal axon arborizations .	43114
Corticomotoneuronal connections in the rat	43114
Corticomotoneuronal connections	43114
the rat	43149
evidence from double-labeling of motoneurons and corticospinal axon arborizations	43158
evidence	43158
double-labeling of motoneurons and corticospinal axon arborizations	43172
double-labeling	43172
motoneurons and corticospinal axon arborizations	43191
motoneurons	43191
corticospinal axon arborizations	43207
J. Comp .	43241
Neurol	43250
311 , 356 -- 366 .	43258
311	43258
356 -- 366	43263
Lindsay , R.M. , 1986 .	43273
Lindsay , R.M.	43273
1986	43288
Reactive gliosis .	43294
: Fedoroff , S. , Vernadakis , A. -LRB- Eds . -RRB-	43314
Fedoroff , S.	43316
Fedoroff	43316
S.	43326
Vernadakis , A. -LRB- Eds . -RRB-	43330
Vernadakis	43330
A. -LRB- Eds . -RRB-	43342
A.	43342
Eds	43346
Astrocytes	43353
Cell	43365
Biology and Pathology of Astrocytes	43370
Biology and Pathology	43370
Astrocytes	43395
Academic Press , Orlando , pp. 231 -- 262	43407
Academic Press	43407
Orlando	43423
pp. 231	43432
262	43441
Miller , M.W. , 1987 .	43446
Miller , M.W.	43446
1987	43460
The origin of corticospinal projection neurons in rat .	43466
The origin	43466
corticospinal projection neurons	43480
rat	43516
Exp .	43521
Brain Res .	43526
Brain	43526
Res	43532
67 , 339 -- 351 .	43537
67	43537
339 -- 351	43541
Miragall , F. , Kadmon , G. , Husmann , M. , Schachner , M. , 1988 .	43550
Miragall , F. , Kadmon , G. , Husmann , M. , Schachner , M.	43550
1988	43604
Expression of cell adhesion molecules in the olfactory system of the adult mouse : presence of the embryonic form of N-CAM .	43610
Expression of cell adhesion molecules in the olfactory system of the adult mouse	43610
Expression	43610
cell adhesion molecules in the olfactory system of the adult mouse	43624
cell adhesion molecules	43624
the olfactory system of the adult mouse	43651
the olfactory system	43651
the adult mouse	43675
presence of the embryonic form of N-CAM	43692
presence	43692
the embryonic form of N-CAM	43704
the embryonic form	43704
N-CAM	43726
Dev .	43733
Biol	43738
129 , 516 -- 531 .	43744
129	43744
516 -- 531	43749
Murray , M. , Goldberger , M.E. , 1974 .	43759
Murray , M. , Goldberger , M.E.	43759
1974	43789
Restitution of function and collateral sprouting in the cat spinal cord : the partially hemisected animal .	43795
Restitution of function and collateral	43795
Restitution	43795
function and collateral	43810
the cat spinal cord : the partially hemisected animal	43847
the cat spinal cord	43847
the partially hemisected animal	43868
J. Comp .	43901
Neurol	43910
158 , 19 -- 36 .	43918
158	43918
19 -- 36	43923
Nash , H.H. , Borke , R.C. , Anders , J.J. , 2002 .	43930
Nash , H.H. , Borke , R.C. , Anders , J.J.	43930
2002	43969
Ensheathing cells and methylprednisolone	43975
Ensheathing cells	43975
methylprednisolone	43997
axonal regeneration and functional recovery in the lesioned adult rat spinal cord	44024
axonal regeneration and functional recovery	44024
the lesioned adult rat spinal cord	44071
J. Neurosci .	44107
22 , 7111 -- 7120 .	44120
22	44120
7111 -- 7120	44124
Paxinos , G. , Watson , C. , 1986 .	44136
Paxinos , G. , Watson , C.	44136
1986	44161
The Rat Brain in Stereotaxic	44167
The Rat Brain	44167
Stereotaxic	44184
second ed	44209
Academic Press , Sydney .	44220
Academic Press	44220
Sydney	44236
Prendergast , J. , Misantone , L.J. , 1980 .	44244
Prendergast , J. , Misantone , L.J.	44244
1980	44278
tracts descending from the midbrain to the spinal cord	44297
tracts	44297
the midbrain	44320
the spinal cord	44336
the result of thoracic funiculotomy in the newborn , 21-day-old , and adult rat	44353
the result	44353
thoracic funiculotomy in the newborn , 21-day-old , and adult rat	44367
thoracic funiculotomy	44367
the newborn , 21-day-old , and adult rat	44392
adult	44421
Exp .	44432
Neurol	44437
69 , 458 -- 480 .	44445
69	44445
458 -- 480	44449
Ramon-Cueto , A. , Plant , G.W. , Avila , J. , Bunge , M.B. , 1998 .	44459
Ramon-Cueto , A. , Plant , G.W. , Avila , J. , Bunge , M.B.	44459
1998	44513
Long-distance axonal regeneration in the transected adult rat spinal cord	44519
Long-distance axonal regeneration	44519
the transected adult rat spinal cord	44556
olfactory ensheathing glia transplants	44608
J. Neurosci .	44648
18 , 3803 -- 3815 .	44661
18	44661
3803 -- 3815	44665
Ramon-Cueto , A. , Cordero , M.I. , Santos-Benito , F.F. , Avila , J. , 2000 .	44676
Ramon-Cueto	44676
A.	44689
Cordero , M.I. , Santos-Benito , F.F. , Avila , J.	44693
2000	44740
Functional recovery of paraplegic rats and motor axon regeneration in their spinal cords by olfactory ensheathing glia .	44746
Functional recovery	44746
paraplegic rats and motor axon regeneration	44769
paraplegic rats	44769
motor axon regeneration	44789
their spinal cords	44816
olfactory ensheathing glia	44838
Neuron 25 , 425 -- 435 .	44866
Neuron 25	44866
425 -- 435	44877
Schnell , L. , Schneider , R. , Kolbeck , R. , Barde , Y. , Schwab , M.E. , 1994 .	44886
Schnell , L. , Schneider , R. , Kolbeck , R. , Barde , Y. , Schwab , M.E.	44886
1994	44952
Neurotrophin-3	44958
corticospinal tract	44995
development	45022
adult spinal cord lesion	45044
Nature 367 , 170 -- 173 .	45070
Nature 367 , 170	45070
173	45087
Schucht , P. , Raineteau , O. , Schwab , M.E. , Fouad , K. , 2002 .	45092
Schucht , P. , Raineteau , O. , Schwab , M.E. , Fouad , K.	45092
2002	45145
Anatomical correlates of locomotor recovery following dorsal and ventral lesions of the rat spinal cord .	45151
Anatomical correlates	45151
locomotor recovery following dorsal and ventral lesions of the rat spinal cord	45176
locomotor recovery	45176
dorsal and ventral lesions of the rat spinal cord	45205
dorsal and ventral lesions	45205
the rat spinal cord	45235
Exp .	45256
Neurol	45261
176 , 143 -- 153 .	45269
176	45269
143 -- 153	45274
Schwab , M.E. , Bartholdi , D. , 1996 .	45283
Schwab , M.E. , Bartholdi , D.	45283
1996	45312
Degeneration and regeneration of axons in the lesioned spinal cord .	45318
Degeneration and regeneration of axons in the lesioned spinal cord	45318
Degeneration	45318
regeneration of axons in the lesioned spinal cord	45335
regeneration	45335
axons in the lesioned spinal cord	45351
axons	45351
the lesioned spinal cord	45360
Physiol	45386
Rev. 76 , 319 -- 370 .	45395
Rev. 76 , 319	45395
370	45409
Takami , T. , Oudega , M. , Bates , M.L. , Wood , P.M. , Kleitman , N. , Bunge , M.B. , 2002 .	45414
Takami , T. , Oudega , M. , Bates , M.L. , Wood , P.M. , Kleitman , N. , Bunge , M.B.	45414
2002	45490
Schwann cell but not olfactory ensheathing glia transplants	45496
Schwann cell	45496
Schwann	45496
cell	45504
olfactory ensheathing glia transplants	45517
hindlimb locomotor performance in the moderately contused adult rat thoracic spinal cord	45564
hindlimb locomotor performance	45564
the moderately contused adult rat thoracic spinal cord	45598
adult rat	45622
J. Neurosci .	45654
22 , 6670 -- 6681 .	45667
22	45667
6670 -- 6681	45671
Tisay , K.T. , Key , B. , 1999 .	45683
Tisay , K.T. , Key , B.	45683
1999	45705
The extracellular matrix	45711
olfactory neurite growth on ensheathing cells	45746
olfactory neurite growth	45746
ensheathing cells	45774
J. Neurosci .	45793
19 , 9890 -- 9899 .	45806
19	45806
9890 -- 9899	45810
Treloar , H.B. , Nurcombe , V. , Key , B. , 1996 .	45822
Treloar , H.B. , Nurcombe , V. , Key , B.	45822
1996	45860
Expression of extracellular matrix molecules in the embryonic rat olfactory pathway .	45866
Expression	45866
extracellular matrix molecules	45880
the embryonic rat olfactory pathway	45914
J. Neurobiol .	45951
31 , 41 -- 55 .	45965
31	45965
41 -- 55	45969
Vincent , A.J. , West , A.K. , Chuah , M.I. , 2003 .	45977
Vincent , A.J. , West , A.K. , Chuah , M.I.	45977
2003	46017
Morphological plasticity of ensheathing cells	46023
Morphological plasticity	46023
ensheathing cells	46051
cAMP and endothelin-1	46085
Glia 41 , 393 -- 403 .	46108
Glia 41	46108
393 -- 403	46117
Weidner , N. , Ner , A. , Salimi , N. , Tuszynski , M.H. , 2001 .	46127
Weidner	46127
N. , Ner , A. , Salimi , N. , Tuszynski , M.H. , 2001	46136
N.	46136
Ner	46140
A.	46145
Salimi	46149
N.	46157
Tuszynski	46161
M.H.	46172
2001	46178
Spontaneous corticospinal axonal plasticity and functional recovery after adult central nervous system injury .	46184
Spontaneous corticospinal axonal plasticity and functional recovery	46184
adult central nervous system injury	46258
Proc	46295
Natl. Acad .	46301
Sci	46313
98 , 3513 -- 3518 .	46318
98	46318
3513 -- 3518	46322
Woodhall , E. , West , A.K. , Chuah , M.I. , 2001 .	46334
Woodhall , E. , West , A.K. , Chuah , M.I.	46334
2001	46373
olfactory ensheathing cells	46388
Nerve	46424
Growth Factor , Brain-derived Neurotrophic Factor , Glia Cell Line-derived Neurotrophic Factor , and their receptors	46430
Growth Factor	46430
Brain-derived Neurotrophic Factor , Glia Cell Line-derived Neurotrophic Factor , and their receptors	46445
Brain-derived Neurotrophic Factor	46445
Glia Cell Line-derived Neurotrophic Factor	46480
their receptors	46528
Mol	46545
Brain Res .	46550
Brain	46550
Res	46556
88 , 203 -- 213 .	46561
88	46561
203 -- 213	46565
Woodhall , E. , West , A.K. , Vickers , J.C. , Chuah , M.I. , 2003 .	46574
Woodhall , E. , West , A.K. , Vickers , J.C. , Chuah , M.I.	46574
2003	46628
Olfactory ensheathing cell phenotype following implantation in the lesioned spinal cord .	46634
Olfactory ensheathing cell phenotype	46634
implantation in the lesioned spinal cord	46681
implantation	46681
the lesioned spinal cord	46697
Cell .	46723
Mol	46729
Life Sci .	46734
60 , 2241 -- 2253 .	46744
60	46744
2241 -- 2253	46748
